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ABSTRACT 
The Role of Mga in the Survival of Pluripotent Cells During Peri-implantation 
Development 
 
Andrew J Washkowitz 
 
The dual specificity transcription factor Mga contains both a T-box binding domain and a 
basic helix-loop-helix zipper (bHLHZip) domain.  Loss of Mga leads to embryonic 
lethality by E5.5.  In vitro blastocyst culture and embryonic stem (ES) cell culture 
identify a lack of pluripotent inner cell mass (ICM) derived cells as the cause of 
embryonic lethality.  Loss of Mga leads to increased apoptosis in E4.5 embryos, though 
there is no decrease in the amount of cell proliferation.  Embryos with mutant Mga have 
fewer pluripotent ICM cells during delayed implantation, though the number of 
differentiated primitive endoderm cells remained initially stable.  Despite the loss of 
pluripotent cells, there is no change in the pattern of expression of Nanog or Oct4, 
pluripotent cell markers, or Gata4, a primitive endoderm marker.  Expression of 
Ornithine Decarboxylase (ODC), the rate-limiting enzyme in the synthesis of cellular 
polyamines, was identified as a possible cause of embryonic lethality based on a similar 
mutant phenotype as well as the presence of E-box sequences in genetic regulation loci.  
ODC is expressed at lower levels in the ICM of Mga mutants.  Blastocyst and ES cell 
culture defects were rescued when cultured in the presence of exogenous putrescine, the 
metabolic product of ODC.  These results suggest a mechanism for Mga to influence 
pluripotent cell survival through interactions with other bHLHZip domain proteins in the 
regulation of the polyamine pool in pluripotent cells of the embryo.   
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Development of the preimplantation embryo 
 Preimplantation development of the mouse embryo occurs over the first 4.5 days 
of embryonic life.  During this time, the embryo goes through radical changes on both a 
morphological and gene expression level to establish the three major cell lineages that 
will contribute to further development after implantation.  When the embryo implants 
between 4.5 and 5.5 days post coitus (defined as E for embryonic day), there are three 
major cell lineages that will contribute to the embryo:  the epiblast (Epi), the 
trophectoderm (TE), and the primitive endoderm (PE).  The Epi gives rise to all of the 
tissues that make up the body of the embryo.  It remains undifferentiated and pluripotent 
largely through the action of Pou5f1 (referred to here by its common name, Oct4), 
Nanog, and Sox2 (Avilion et al., 2003; Loh et al., 2006; Nichols et al., 1998; Silva et al., 
2009).  Pluripotency relies both on the repression of differentiation factors as well as the 
activation of pluripotency factors. In contrast, the PE and the TE have already undergone 
initial stages of differentiation and will eventually give rise to most of the extraembryonic 
structures present during gestation.  Development and differentiation of embryonic 
tissues relies on tight transcriptional control of the embryonic genome. 
 
Activation of the zygotic genome 
 Transcription in the fertilized egg initially relies on maternally-derived mRNA 
transcripts deposited during oogenesis.  It is not until the late one-cell/2-cell stage that an 
initial wave of zygotic transcription occurs (Hamatani et al., 2004).  This wave of 
transcription, collectively referred to as the zygotic genome activation (ZGA), is both 
short-lived and is accompanied by rapid downregulation of ZGA-target genes and 
degradation of target transcripts.  The zygotic genes that become active during initial 
ZGA are characterized as coding for basic cellular machinery including ribosomal 
proteins, RNA binding, proton transport, among others.  Simultaneously, during the time 
of ZGA, maternal transcripts are degraded rapidly, allowing the zygotic genome to 
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become the main source of genetic instructions for further development (Paynton et al., 
1988).   
 It is not until a second wave of transcription from the 4-cell stage to the 8-cell 
stage that genes specific for development of the pre-implantation embryo begin to be 
transcribed.  While transcription of these genes is transient before being immediately 
decreased, these are the genes that have been shown to be responsible for patterning the 
pre-implantation embryo.  This wave of transcription includes genes such as Pou5f1 and 
Nanog, pluripotency factors in the ICM, as well as genes such as Gata3 and Irx3, markers 
of trophoblast (Tanaka et al., 2002).    
 The presence of maternal transcripts is essential for development, but is often a 
complicating factor in the analysis of early gene function.  Many genes are essential for 
embryonic development, but are deposited in the egg as either transcript or protein before 
ZGA.  This makes loss-of-function studies difficult as the embryonic genome may 
contain loss-of-function alleles while the maternally derived transcripts or proteins are 
functional.  This will mask potential embryonic phenotypes while the maternal transcript 
or protein persists.   
 
Differentiation of the trophectoderm 
 The earliest zygotic cell divisions and the activation of the zygotic genome leave 
all daughter cells with the same developmental totipotency.  The first cell lineage 
restriction is the differentiation of the trophoblast, the tissue that will become the 
placenta.  Initiation of differentiation begins when cells of the 8-cell zygote divide 
asymmetrically to generate “inner” and “outer” populations of cells (Johnson and 
McConnell, 2004).  During this time, “outer” cells that will eventually become TE 
upregulate the homeobox gene Cdx2 (Jedrusik et al., 2008).  Cdx2 appears to be the key 
factor for the differentiation of trophoblast as embryos mutant for Cdx2 do not 
downregulate the ICM markers Oct4 and Nanog in the presumptive trophoblast cells 
resulting in the death of these “outer” cells (Strumpf et al., 2005).  Cdx2 also plays a role 
in maintaining the structural integrity of the embryo via E-cadherin adherins junctions 
present in the trophoblast during blastocyst formation (Strumpf et al., 2005).  
Eomesodermin (Eomes) also plays a role in proliferation of the trophoblast, though 
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mutants lacking Eomes are still able to form a TE layer suggesting that it acts 
downstream of Cdx2 (Teo et al., 2011).   
Conversely, Oct4 and Nanog are initially expressed throughout the embryo, but 
eventually become restricted to the ICM by the action of trophoblast and TE 
differentiation genes such as Cdx2 and Eomes.  Both Oct4 and Nanog have been shown 
to be repressors of early differentiation: Oct4 represses trophoblast differentiation and 
Nanog represses extra-embryonic endoderm and PE (Mitsui et al., 2003; Nichols et al., 
1998).   In this way, there is a feedback mechanisms where cells of the trophoblast 
downregulate ICM genes, and cells of the ICM downregulate trophoblast genes.   
 
Differentiation of the primitive endoderm 
 The second cell lineage restriction in the embryo is the formation of the PE, a 
monolayer of cells underlying the Epi that will eventually give rise to the yolk sac.  The 
differentiation of the PE begins at E3.5 when cells of the ICM begin to differentially 
express the pluripotency marker Nanog and the PE marker, Gata6 in a “salt and pepper” 
pattern (Chazaud et al., 2006).  Gata6 is upregulated by Fgf signaling through the adaptor 
protein Grb2, though the mechanism for targeting only a subset of ICM cells is not 
understood (Chazaud et al., 2006).  Tracking of presumptive PE cells using another 
marker of PE, Pdgfrα, shows that they can either migrate to the PE monolayer or undergo 
apoptosis, suggesting a role for cell adhesion molecules in the sorting and survival of PE 
cells (Plusa et al., 2008).  Once PE cells are formed, they rely on the Epi to survive as 
Nanog-deficient embryos are able to initially form a PE, which then degenerates (Silva et 
al., 2009).   
 
The T-box transcription factors in preimplantation embryonic development and 
pluripotency 
 
 The necessity of transcriptional control of differentiation during preimplantation 
development suggests that different families of transcription factors can contribute to this 
process.  The T-box transcription factors are an ancient and evolutionarily conserved 
family of transcription factors necessary for a large number of developmental processes 
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(Naiche et al., 2005).  In mouse, there are 17 T-box factors that can be subdivided into 5 
subfamilies based on sequence similarity.   All of the T-box factors share a common 
DNA binding domain, the T-box, which can bind the T-box binding element (TBE), a 
palindromic sequence with two T-half sites (5’-AGGTGTGAAATT-3’) (Kispert and 
Herrmann, 1993).  Dimers of Brachyury are able to bind this sequence, with each 
monomer binding one T-half site of the TBE (Papapetrou et al., 1997).  Different T-box 
factors bind their respective T-sites in various homo- and heterodimeric combinations, as 
well in competition with each other or other transcription factors (Habets et al., 2002; 
Sinha et al., 2000).   
 Although detected in other organisms as early as the oocyte stage of development, 
most T-box factors are only functionally necessary during gastrulation and organogenesis 
(Gibson-Brown et al., 1998; Greulich et al., 2011; Showell et al., 2004).  Nonetheless, 
there is evidence of a role for two T-box genes during blastocyst formation and in the 
maintenance or acquisition of pluripotency.   
 
Tbx3 
 Tbx3 transcripts are first detected in the ICM of E3.5 blastocysts (Bollag et al., 
1994; Chapman et al., 1996).  Despite this expression, the role of Tbx3 in the ICM is 
unclear.  Homozygous loss-of-function Tbx3 mutants have no phenotype at E3.5, though 
there is 50% embryonic lethality by E11.5 with the rest dying by E16.5, most likely due 
to yolk sac or cardiac deficiency (Davenport et al., 2003; Mesbah et al., 2008).  
Nonetheless, Tbx3 is critical for the function of embryonic stem (ES) cells.  
Similar to their in vivo analog, the ICM, undifferentiated ES cells express Tbx3.  This 
expression decreases as the ES cells differentiate implicating Tbx3 in the maintenance of 
pluripotency (Lu et al., 2011).  This function is supported by the detection of Tbx3 in a 
pluripotency transcriptional module involving factors such as Oct4 and Nanog that is able 
to activate transcription of pluripotent factors and repress differentiation genes (Kim et 
al., 2008).  Moreover, ectopic Tbx3 expression from a viral plasmid leads to increased 
efficiency of derivation of induced pluripotent stem cells (iPSC) (Han et al., 2010).  
Rather than promoting pluripotency, though, Tbx3 appears to function similarly to Oct4 
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and Sox2 by repressing differentiation, in this case differentiation into mesoderm, 
ectoderm, and neural crest cell fates (Ivanova et al., 2006).   
In contrast to its role in repression, Tbx3 is also able to promote differentiation of 
ES cells into extraembryonic endoderm (ExEn).  Overexpression of Tbx3 in ES cells 
induces differentiation of ExEn cells as gauged both by morphology and Gata6 
expression (Lu et al., 2011).  This duality suggests that, like other factors involved in 
pluripotency, Tbx3 renders ES cells poised to differentiate when the proper signals are 
received.  These transcription factors act as repressive factors when ES cells are to 
remain pluripotent, but can quickly switch to activators when differentiation is induced 
(Bernstein et al., 2006; Washkowitz et al., 2012).   
  
Eomesodermin 
 The only other T-box transcription factor that has been shown to play a role in 
preimplantation development is Eomes.  Eomes is first detected in the trophoblast lineage 
at E3.5 and continues to be expressed in its derivative, the extraembryonic ectoderm of 
postimplantation embryos (Hancock et al., 1999; Russ et al., 2000).  Eomes homozygous 
mutations are embryonic lethal soon after implantation due to a defect in trophoblast 
development and failure of formation of trophoblast stem cells.  Eomes likely acts 
downstream of the homeobox factor Cdx2 in the proliferation and development of the 
trophoblast (Strumpf et al., 2005).   
In the pluripotent ICM and Epi, Eomes is repressed by Nanog, Sox2, and Oct4.  
Later, during gastrulation, Eomes promotes the differentiation of the embryonic germ 
layers by repressing mesoderm and pluripotency genes and activating definitive 
endoderm (DE) genes (Teo et al., 2011).  Eomes also regulates the E-cadherin-mediated 
epithelial-to-mesenchymal transition critical for cell movement and mesoderm 
specification, thus providing cues for cell specification along the anterioposterior axis 





The Max network of basic-helix-loop-helix-leucine zipper transcription factors in 
early embryonic development and pluripotency 
 Another group of transcription factors known to play a role in preimplantation 
development is the basic-helix-loop-helix-leucine zipper (bHLHZip) domain genes of the 
Max network.   The Max network proteins are  transcription factors that bind the 
canonical DNA sequence, the E-box (5’-CACGTG-3’) (Grandori et al., 2000; Hurlin and 
Huang, 2006).  This network is composed of the bHLHZip genes Max and Mga, as well 
as members of the Myc, Mad, and Mnt families of genes. Most of these genes were 
identified by the binding of their gene products to Max, highlighting the centrality of 
Max in the function of this network (Ayer et al., 1993; Hurlin et al., 1999; Hurlin et al., 
1995; Meroni et al., 1997; Zervos et al., 1993).   
 Max lies at the center of this transcriptional network and is required for all 
proteins of the network to function.  Though Max alone is able to homodimerize and bind 
the canonical E-box, it is transcriptionally inert.  Similarly, the other members of this 
family are unable to bind DNA alone leaving them also transcriptionally inert as 
monomers.  It is only through heterodimerization with Max that the other proteins in the 
network are able to activate or repress transcription of their E-box-containing target 
genes.  In this way, each protein’s activity is modulated by the presence or absence of the 
other proteins in the network (Baudino and Cleveland, 2001; Meroni et al., 2000; Walker 
et al., 2005).  Mga is unique among the members of the bHLHZip domain family 
members because of the presence not just of the bHLHZip DNA binding domain, but a T-
box binding domain as well (Hurlin et al., 1999).     
The importance of this network was first noted in 1981 when the amplification 
and overexpression of the proto-oncogene c-Myc was found in Avian Leukosis Virus 
(ALV)-induced lymphoid leucosis (Hayward et al., 1981).  Myc has since been linked to 
more than 40% of human cancers (Zeller et al., 2003).  Despite their importance in a 
variety of cellular contexts, only a subset of the Max-interacting transcriptional network 







 In both mouse and zebrafish, Max transcripts are found ubiquitously throughout 
development (Domashenko et al., 1997; Schreiber-Agus et al., 1993).    In mouse, there 
are maternal stores of Max in unfertilized eggs, as well as zygotic Max produced in all 
cells of the embryo throughout development (Shen-Li et al., 2000).   
Despite its near universal expression, zygotic Max appears to be dispensable for 
development through the preimplantation period, though the maternal stores of the 
protein could abrogate a need for newly produced Max.  Homozygous Max mutant 
embryos are recovered at a mendelian frequency at E3.5, but are recovered at a lower rate 
at E6.5 and are not recovered at all by E8.5. Mutant embryos at E6.5 are 50-70% smaller 
than controls and have no demarcation between embryonic cell layers and no 
morphologically distinct embryonic features.  Mutant embryos also have lower 
proliferation rates at E6.5, and though there is no accompanying apoptosis, it is possible 
that earlier waves of apoptosis were missed during analysis (Shen-Li et al., 2000).   
The importance of Max during the peri-implantation period suggests a necessity 
for active Max network transcription factors, though functional redundancy and maternal 




c-Myc is first transcribed at the 4-cell stage and continues to be expressed until the 
formation of the blastocyst (Domashenko et al., 1997).  The importance of this early 
expression is unclear as c-Myc homozygous mutant mice survive until E10.5 when they 
die with abnormalities in the heart, pericardium, neural tube, and other structures (Davis 
et al., 1993).  When c-Myc deletion is confined to the Epi, embryos die before E12 of 
severe anemia and functionally defective hematopoietic stem/progenitor cells, but have 
none of the structural deficiencies in the formation of the heart or neural tube (Dubois et 
al., 2008).  The difference in embryonic lethality when c-Myc is deleted in the Epi-
derived tissues alone compared to the Epi- and TE-derived tissues suggests separate 
developmental roles for c-Myc:  The lack of c-Myc in the TE-derived placenta could lead 
to placental insuffiency and contribute to the E10.5 lethality of mutant c-Myc embryos, 
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while the lack of a hematopoeitc stem-cell population in the embryo could account for the 
later lethality of the Epi-restricted mutant c-Myc embryos.   
Complementary to c-Myc’s role in the development of a multipotent 
hematopoietic stem-cell population, c-Myc has also been found to expressed in 
pluripotent ES cells (Murphy et al., 2005), though its role there is unclear.  c-Myc mutant 
ES cells are grossly normal and c-Myc is not part of the core pluripotency network of 
Oct4, Sox2, and Nanog (Davis et al., 1993; Kim et al., 2008).  Nonetheless, c-Myc’s 
importance in pluripotency is evident as efficient derivation of iPS cells with c-Myc is not 
possible (Takahashi and Yamanaka, 2006).  This discrepancy may be explained by the 
presence of the closely related protein N-myc in ES cells.  Indeed, ES cells that have both 
mutant c-Myc and mutant N-myc do not maintain pluripotency or self-renewal, 
highlighting a necessary role for these genes in ES cells (Varlakhanova et al., 2010).     
c-Myc has also been proposed to form the core of a transcriptional module that 
serves to amplify global transcription in ES cells (Nie et al., 2012).  In activated 
lymphocytes, c-Myc was shown to bind to the promoters of virtually all genes that were 
upregulated compared to non-activated lymphocytes, regardless of whether they 
contained E-boxes in them.  The binding of c-Myc to promoters of expressed genes with 
or without E-boxes correlated with an increase in their expression levels in ES cells.  This 
binding was also associated with an increase in RNA polymerase II.  Because c-Myc-
mediated amplification of transcription was not limited to genes with E-boxes in their 
promoters, c-Myc may function as a global transcriptional modulator for the entire 
genome (Nie et al., 2012).  This functionality is also present in T-lymphocytes and 
Burkitt’s lymphoma cells suggesting a universal mechanism for c-Myc–mediated gene 
regulation (Lin et al., 2012).   
 
N-myc 
 As with c-Myc, the closely related transcription factor N-myc is also thought to 
play a role in preimplantation development.  N-myc transcripts were observed at low 
levels throughout the E6.5 embryo to the exclusion of the TE (Downs et al., 1989).  
Later, N-myc transcripts were detected during gastrulation and embryonic time points 
thereafter, notably in the developing nervous system.  (Stanton et al., 1992).  Though not 
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examined earlier in the embryo, N-myc is also expressed in ES cells, suggesting that 
expression may be found in the ICM (Sawai et al., 1991).   
 The role of N-myc in pluripotency and the development of the early embryo is 
unclear.  Multiple studies using different mutant alleles have found that embryos with 
homozygous N-myc mutations are embryonic lethal during organogenesis (Sawai et al., 
1993; Stanton et al., 1992), suggesting that N-Myc is dispensable during earlier stages.  
However, as with c-Myc, ES cells that carry disrupted versions of both c-Myc and N-myc 
do not maintain pluripotency or self-renewal (Varlakhanova et al., 2010).  Derivation of 
iPS cells is also normal when N-myc is substituted for c-Myc (Blelloch et al., 2007).  
Moreover, the transgenic replacement of the coding sequence of c-Myc with that of N-
myc results in viable and fertile mice with no apparent defects, highlighting a redundant 




 Mga (MGI: 1352483, synonyms C130042M01Rik, D030062C11Rik, Mad5), the 
least studied of the Max-network of transcription factors, is also thought to play a role in 
the development of the embryo.  Mga was first identified in a yeast two-hybrid screen for 
interacting partners of Max.  Mga was identified using E9.5 and E10.5 cDNA libraries 
and the full length sequence was constructed using an E14.5 kidney cDNA library 
(Hurlin et al., 1999).  Mga has since been found to span 73kb of genomic DNA on 
chromosome 2 and contain 24 exons.  The mature RNA is ~9kb and codes for a protein 
of 3006 amino acid residues.  There are two splice forms that differ by the 
inclusion/exclusion of the 14th exon.       
 Domain analysis reveals the presence not just of a bHLHZip DNA binding 
domain, but also a T-box DNA binding domain, making Mga a dual-specificity 
transcription factor.  Unlike other T-box transcription factors, the T-box in Mga is fully 
encoded within a single exon leading to the hypothesis that it is the product of the 
retrotransposition of the T-box of a Tbx6-related cDNA, the most closely related T-box 
transcription factor (Lardelli, 2003)(Fig 1).    




Figure 1.  Phylogenetic analysis of vertebrate T-box sequences.  A.  ClustalW alignment 
of translated T-box sequences.  Mga and Tbx6 are highlighted in red.  B.  Phylogenetic 
tree derived by parsimony analysis of alignment of (A).  Mga is highlighted in red.  
Adapted from (Lardelli, 2003).  Hs, Homo sapiens; Mm, Mus musculus; Dr, Danio rerio; 
Gg, Gallus gallus. 
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In vitro, Mga has been shown to bind the TBE as well as the E-box.  Binding of 
Mga to the E-box is dependent on Max dimerization, while binding to the TBE can occur 
either independently of Max or as a dimer with Max.  When bound to E-box sites as a 
heterodimer, Mga is able to act as a transcriptional activator.  However, when bound to a 
TBE, Mga is able to repress transcription when bound alone, but to activate transcription 
when bound with Max (Hurlin et al., 1999).  This duality suggests that Max can regulate 
the activity of Mga not only by regulating its binding to the E-box, but also by acting as a 
switch of transcriptional activity on T-box targets.   
 Mga appears to be widely expressed during development.  In zebrafish, Mga 
mRNA was detected as a maternal transcript in the fertilized egg at the 1-cell stage and is 
expressed widely throughout later development (Rikin and Evans, 2010).  In mouse, the 
expression is more restricted with mRNA first detected at E3.5 and later at E6.5 through 
E10.5 (Hu et al., 2009).  In situ hybridization localized E3.5 expression to the pluripotent 
ICM (Yoshikawa et al., 2006), and expression of both RNA and protein has been 
detected in ES cells, the in vitro analog of the ICM (Hu et al., 2009; van den Berg et al., 
2010).  Mga RNA was also detected during organogenesis in a variety of organs 
including the limb buds, branchial arches, and tail region, though control assays were not 
shown (Hurlin et al., 1999) and independent verification has not been possible (our 
unpublished results). 
 Very few studies have addressed the role of Mga during embryonic development.  
In zebrafish, morpholino depletion of Mga in fertilized eggs results in defects in the 
brain, heart, and gut derivatives, though no common mechanism was found.  In the heart, 
there was an absence of looping that was partially a result of overexpression of Gata4 
transcripts, indicating a transcriptional repression role of Mga.  The brain, however, was 
shown to have an increase of apoptosis that was p53 dependent, indicating a cell survival 
role for Mga (Rikin & Evans, 2010).   
In mouse, Mga appears to have a role in the pluripotency program.  In ES cells, 
Mga has been shown to be in a complex with the pluripotency factor Oct4, a necessary 
transcriptional activator for pluripotency (Hammachi et al., 2012).  When Mga is 
depleted with siRNA, ES colonies showed a decrease in the transcription of Oct4, Sox2, 
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and Nanog suggesting a transcriptional activation role for Mga in ES cells (Hu et al., 
2009; van den Berg et al., 2010).  
In addition to its role as a transcription factor, Mga may also modulate 
transcription by recruiting other complexes to target genes.  Mga has been found in 
polycomb repression complexes with PRC1B and E2F-6 in both ES cells and HeLa cells 
(Illingworth et al., 2012; Ogawa et al., 2002).  In HeLa cells, the presence of Mga in this 
complex allows chromatin modification and silencing of T-box and E-box targets, 
suggesting that Mga is able to regulate transcription both on a direct transcriptional level 
as well as an epigenetic level. 
 
Aims of this research 
 
Our initial experiments indicated that Mga was critical for peri-implantation 
development.  It is possible that Mga is necessary for peri-implantation development 
because it regulates key transcriptional targets through its interaction with Max network 
proteins.  We studies how Mga affects preimplantation development using 4 primary 
systems.  First, we used blastocyst culture of embryos lacking Mga to directly observe the 
growth and development of the peri-implantation embryo in the absence of Mga.  
Second, we derived ES cells with a conditional Mga allele to observe any effects that 
mutation of Mga has on the growth and differentiation of ICM analogues.  Third, we used 
immunofluorescence of E4.5 day embryos to assess the expression of cell layer 
differentiation and characterize the growth and apoptosis of embryos lacking Mga.  
Finally, we used hormonally induced diapause to assay maintenance of pluripotency in 
embryos lacking Mga in the absence of the rapid cell division characteristic of peri-








The role of Mga in preimplantation development 
Function of the Mga mutant allele 
A conditional Mga mutation was generated by the German Gene Trap Consortium 
(GGTC), Mouse Genome Informatics (MGI) allele MgaGt(E153E01)Wrst.  This is a 
multipurpose allele from which additional alleles can be derived.  In the following, the 
alleles are referred to as MgaGT (for gene trap), MgaInv (for FLP-recombinase inverted 
gene trap) or MgaRe-inv (for Cre-recombinase re-inverted gene trap).  
The Mga allele was made with a gene trap construct that contains a splice 
acceptor and β-galactosidase-neomycin resistance (β-geo) fusion protein cassette that is 
flanked by 4 sets of heterotypic LoxP and FRT sites (Fig 2).  In its original MgaGT 
orientation, the upstream exon donates a splice site that is accepted by the gene trap 
cassette rather than the endogenous allele.  This creates a truncated fusion protein that 
carries a β-geo reporter under the control of the Mga promoter.  When treated with Flp 
recombinase, the cassette is inverted to the MgaInv configuration and the splice acceptor is 
put in the wrong orientation to accept the upstream splice, allowing the wild type 
transcript to be produced.  When treated with Cre recombinase, the cassette is flipped to 
the MgaRe-inv configuration, once more producing the β-geo fusion protein.  These 
mechanisms allow the MgaGT and MgaRe-inv alleles to act as mutant reporters and the 
MgaInv allele to act as a conditional-mutation allele (Fig 2)(Schnutgen et al., 2005). 
ES cell clones were isolated from E14Tg2a ES cells (Sv129P2) after retroviral 
infection using rsFlpRosaβgeo (FlpRBG; www.genetrap.de). The insertion of FlpRBG in 
intron 3 of Mga was identified by splinkerette PCR (Horn et al., 2007).   
Breeding with Mga mutants 
All embryos and adults produced during the course of experiments were routinely 
genotyped by PCR.  MgaGT/+ mice genotyped at weaning were recovered at the expected 
Mendelian frequency (46/88 from MgaGT/+ x Mga+/+ matings; X2 = 0.18, p=0.67) and 





Figure 2.  The gene trap cassette and Mga mutations produced from the FlpRBG cassette.  
The FlpRBG targeting vector utilizes a gene trap strategy for the creation of a mutant 
reporter of Mga.  The MgaGT allele orients a splice acceptor-β-galactosidase-neomycin 
resistance cassette (top) to accept the upstream exon’s splice site and create a mutant 
truncated reporter protein.  After treatment with Flp recombinase (which results in 
inversion, step 1 and excision, step 2), the splice acceptor  is no longer in the proper 
orientation to accept the upstream splice and a wild type transcript is produced.  After 
further treatment with Cre recombinase, inversion (step 3)  and excision (step 4) occur to 
produce the MgaRe-inv allele, which functions like the MgaGT allele: a truncated reporter 




dominant negative effect (Table 1).  No MgaGT/GT mice were recovered at weaning in 19 
litters from inter se matings of MgaGT/+ mice (0/84; X2 = 28.64, p<0.0001) indicating 
homozygous lethality before that time (Table 1).  MgaGT/+ mice were also bred with a 
constitutively active FlpE recombinase-expressing mouse to generate the inverted 
conditional allele, MgaInv (Fig 2).  MgaInv/+ mice were born at the expected frequency 
(7/13 from MgaInv/+ x Mga+/+ matings; X2 = 0.33, p = 0.56) indicating that the conditional 
MgaInv/+ allele did not have a heterozygous or a dominant negative effect (Table 1).  
Homozygous MgaInv/Inv mice, however, were recovered at only ~50% of the expected 
frequency (19/150 from MgaInv/+ x MgaInv/+ matings; X2 = 13.45, p = 0.001) indicating 
that the conditional MgaInv allele is not fully functional (Table 1).  This conditional allele 
was insufficient to compensate for the MgaGT mutation of a second allele as no MgaGT/Inv 
mice were recovered (0/22 from MgaInv/Inv x MgaGT/+ matings; X2 = 22, p<0.0001) (Table 
1).  
 
The role of Mga during implantation 
Dissection of the uteri of females from inter se MgaGT/+ matings at E9.5 – E11.5 
revealed empty implantation chambers with cellular debris or a few trophoblast giant 
cells in approximately ¼ of the deciduae examined (6/25; from the Mendelian ratios, X2 
= 6.37, p=0.04).  Trophoblast giant cells from one of these decidua were recovered and 
proved to be MgaGT/GT when genotyped by PCR.  Implantation sites with evidence of 
embryonic lethality were present at E5.5 as well, where approximately ¼ of the deciduae 
dissected were empty (9/44; from the Mendelian ratios, X2 = 11.69, p=0.003).   
Histological examination of whole uteri at E5.5 and E6.5 showed instances of cellular 
debris with isolated trophoblast giant cells in approximately ¼ of the decidual swellings 
examined (10/39 at E5.5; from the Mendelian ratios, X2 = 0.55, p=0.46; 4/10 at E6.5; 
from the Mendelian ratios, X2 = 1.20, p = 0.27) (Fig 3).  At E4.5, MgaGT/GT embryos were 
recovered from uterine flushes at approximately 80% of the expected Mendelian 
frequency (49/245; X2 = 10.91, p = 0.004) and appeared morphologically normal when 
compared to their wild type or heterozygous littermates (Fig 4).  Similarly, MgaGT/GT 
embryos were recovered at the expected Medelian frequency at E3.5 (21/89; X2 = 1.30, p 




Table 1.  Genotype distribution at weaning of progeny from Mga mutant crosses.    X2 




  Mating 
Genotype 
X2, p +/+ +/- -/- 
Mga+/+ x MgaGT/+ 46 42 N/A X2 = 0.18, p=0.67 
MgaGT/+ x MgaGT/+ 31 53 0 X2 = 28.64, p<0.0001 
Mga+/+ x MgaInv/+ 5 7 N/A X2 = 0.33, p=0.56 
MgaInv/+ x MgaInv/+ 38 93 19 X2 = 13.45, p=0.001 




Table 2.  Genotype distribution of embryos from MgaGT/+ x MgaGT/+ crosses.  ND 
indicates that no genotype was obtained though an implantation site (E5.5) or an empty 
decidua (E9.5-E11.5) was observed.  X2 and p values were calculated assuming a 





+/+ +/GT GT/GT ND 
E3.5 27 41 21 0 X2=1.36, p=0.51 
E4.5 83 113 49 0 X2=10.91, p=0.004 
E5.5 12 23 0 9 X2=11.69, p=0.003 




Figure 3.  Histological sections of implantation sites at E5.5 and E6.5. Embryo 
degeneration (B, D) was detected in 10/39 decidual swellings at E5.5 and 4/10 swellings 
at E6.5 with trophoblast giant cells seen at E5.5 (yellow arrows).  Other implantation 
sites contained morphologically normal embryos (A, C).  MB. Maternal blood;  Dc. 
Decidua; Epi. Epiblast; EPC, Ectoplacental cone; PE, Primitive endoderm; ExEc, 




Figure 4.  Preimplantation embryos at E3.5 and E4.5. ICM, Inner Cell Mass; Epi, 






indicate that MgaGT/GT embryos implant in the uterus but die shortly thereafter; thus it is 
likely that Mga plays an essential role in the peri-implantation development of the 
embryo. 
 
The function of Mga in the development of the ICM 
Mga expression in the pluripotent tissues of the embryo 
To assess the contribution of Mga to peri-implantation development, embryonic 
expression of Mga was assessed using the β-galactosidase reporter functionality of the 
MgaGT allele.  There was robust β-galactosidase activity in the Epi of MgaGT/+ embryos at 
E5.5, 6.5, and 7.5 to the exclusion of the PE or extraembryonic tissues (Fig 5E-J).  
Standard X-gal staining was not sufficient for detection in preimplantation stages, but the 
more sensitive S-gal method for β-galactosidase detection showed staining in the Epi at 
E4.5 in MgaGT/+ embryos, but not in Mga+/+ embryos (Fig 5B, C).  While neither X-gal 
nor S-gal showed staining at E3.5, RT-PCR for Mga in wild type embryos demonstrated 
expression at E3.5 (Fig 5A, D).  This was the earliest time point that Mga was expressed, 




The role of Mga in ICM development 
To test the capacity of MgaGT/GT for survival and differentiation outside the 
uterine environment, embryos were isolated at E3.5 from MgaGT/+ x MgaGT/+ matings 
prior to time of death and cultured in vitro before genotyping retrospectively by PCR.  
MgaGT/+ cultures were stained with X-gal to assess β-galactosidase reporter activity.  The 
ICM of the blastocyst cultures showed strong X-gal staining to the exclusion of the 
trophoblast 48 hours after starting culture, indicating that the in vitro culture system 
initially recapitulated the embryonic expression of Mga in the Epi before vanishing (Fig 
6).     
While MgaGT/GT embryos (n=11) were able to attach to the tissue culture substrate 




Figure 5.  Mga expression in embryos using the β-galactosidase reporter and RT-PCR.  
A-C. No β-galactosidase activity was observed in blastocysts at E3.5 using X-gal stain 
(A).  S-gal staining was present in the Epi of E4.5 MgaGT/+ embryos (B), but not in 
Mga+/+ embryos (C).  D. RT-PCR on pooled embryos did not detect any Mga transcripts 
at E0.5 or E2.5, but expression was present at E3.5 and at E4.5.  E-J. β-galactosidase 
staining was observed in the Epi of whole mounts at E5.5 (E), E6.5 (G), and E7.5 (I).  
Parafin sections (nuclear fast red counterstain) confirm Epi staining of β-galactosidase 
from E5.5 (F), E6.5 (H), and E7.5 (J) embryos.  ExEc, Extraembryonic Ectoderm; Epi, 
Epiblast; ExEn, Extraembryonic Endoderm.  Scale bars: 40µm. 
!!
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Figure 6.  β-galactosidase activity during in vitro culture of E3.5 blastocysts.  Blastocyst 
cultures from MgaGT/+ embryos were stained with X-gal.  The ICM of the cultures 
showed β-galactosidase activity after 48 hours of culture reflecting reporter expression.  





thrive, resulting in smaller ICM outgrowth surface area by 4 days of culture.  In contrast 
to the normal-appearing trophoblast cells, the ICM cells were sparse and did not form the 
multicellular or cystic structures of their Mga+/+ and MgaGT/+ littermates (n=35) when 
examined 4 days after culture (Fig 7A).  Quantification of the surface area of the ICM 
outgrowth showed similar wild type and mutant ICM outgrowths after 2 days of culture 
before the mutants either stagnated in their growth or contracted by 4 days of culture (Fig 
7B, C).  In conjunction with the expression data, this indicates a failure of ICM survival 
as a contributing factor in the embryonic lethality of MgaGT/GT embryos.   
 
The role of Mga in embryonic stem cell culture 
To confirm the importance of Mga for the survival of the ICM, we used the in 
vitro analog of the ICM, ES cells.  Because MgaGT/GT ICMs did not grow when cultured, 
we derived ES cells from embryos carrying the conditional allele MgaInv/Inv that also 
harbored the inducible Cre recombinase gene CreERT2 integrated into the Rosa26a locus 
(de Luca et al., 2005).  MgaInv/Inv; CreERT2 ES cells were morphologically 
indistinguishable from MgaInv/+ ES cells and grew at similar rates when cultured under 
normal conditions (Fig 8A, B, D).  Additionally, MgaInv/Inv; CreERT2 ES cells expressed 
pluripotency markers Oct4 and Nanog as expected (Fig 8C).   
Upon inversion of the conditional allele by addition of 4-hydroxytamoxifen to the 
culture, however, MgaInv/Inv; CreERT2 colonies were sparser and smaller than either 
MgaInv/+ cells or MgaInv/Inv; CreERT2 cells treated with ethanol vehicle alone when 
viewed at low magnification as a population, though the colony morphology was normal 
in the individual surviving colonies (Fig 9A).  Quantification of cell number at 24-hour 
intervals revealed an approximate 35% decrease in the number of cells in cultures where 
inversion had been induced when compared to uninduced MgaInv/Inv; CreERT2 and 
control cell lines (Fig 9B).  Genotyping of the surviving colonies showed that there was 
incomplete inversion of the MgaInv allele regardless of the length of tamoxifen treatment 
(Fig 9C).  To ensure that the optimal dose was used to induce inversion, colonies were 
grown in increasing concentrations of tamoxifen.  Both MgaInv/Inv; CreERT2 and MgaInv/+ 
cultures had fewer colonies present as tamoxifen dose was increased past previous 




Figure 7.  In vitro culture of E3.5 blastocysts.  A. ICM outgrowth from MgaGT/GT 
embryos appeared smaller than controls at 3 or 4 days of culture by phase contrast 
microscopy.  B, C. Measurement of the surface area at 4 days showed that the ICM 
surface area of MgaGT/GT embryos was smaller that controls (B), although the trophoblast 




Figure 8.  Growth and differentiation of MgaInv/Inv; CreERT2 ES cells.  A-B. ES cell 
colonies appeared morphologically similar to MgaInv/+ ES cells. C.  
Immunohistochemistry for normally expressed pluripotency markers Nanog (green) and 
Oct4 (red) in MgaInv/Inv; CreERT2 ES cells.  Nucleii are stained with Hoeschst (blue).  D.  





Figure 9. ES cells treated with tamoxifen to induce inversion to the mutated allele.  A.  
MgaInv/Inv; CreERT2 ES cells formed smaller and more sparse colonies when treated with 
4-hydroxytamoxifen than when untreated, though colony morphology appeared normal in 
tamoxifen treated cells (A, inset).  B.  MgaInv/Inv; CreERT2 ES cells grew at a slower rate 
from the time of tamoxifen addition at t=0.  C.  Surviving colonies showed partial 




cultures remained constant, indicating that greater levels of inversion could not be 
induced before tamoxifen levels became toxic to cells (data not shown).  Together, these 
results indicate that Mga is necessary for the survival of ES cells and that the surviving 
colonies were those that had escaped inversion and thus had at least one functional Mga 
allele.   
Apoptosis and cell proliferation in MgaGT/GT embryos 
Reduced ICM outgrowth of MgaGT/GT blastocyst cultures and reduced growth of 
inversion-induced MgaInv/Inv; CreERT2 ES cells suggests an increase in cell death and/or 
a decrease in cell proliferation in the ICM or ICM derivatives such as the Epi.  To 
investigate cell proliferation, immunofluorescence with antibodies against 
phosphorylated histone H3 (phospho-H3) was performed.  Counts of the number of 
positive cells in the Epi did not reveal any difference in the number of mitotic cells in 
MgaGT/GT embryos (3.1 +/- 0.8) compared to Mga+/+ and MgaGT/+ embryos (2.8 +/- 0.3) at 
E4.5 (Fig 10B) (t=0.259, p=0.65) (Figure 10C).  The appearance of phospho-H3 nuclear 
staining can also be used to assess the stage of mitosis that cells are in: prophase nuclei 
have uniform phospho-H3 staining throughout the nucleus while metaphase and anaphase 
nuclei have more punctate staining indicative of condensed chromatin.  The number of 
cells that were in prophase in MgaGT/GT embryos (1.6 +/- 0.5) was not different from the 
number of cells in Mga+/+ and MgaGT/+ embryos (1.8 +/- 0.3).  Similarly, the number of 
cells in metaphase or anaphase in MgaGT/GT embryos (1.5 +/- 0.6) was not different from 
Mga+/+ and MgaGT/+ embryos (1.0 +/- 0.2).   Together, these data indicate that there is no 
defect in progression through the cell cycle in MgaGT/GT embryos (Fig 11) (Brenner et al., 
2003).    
To investigate apoptosis, immunofluorescence of E4.5 day embryos with 
antibodies against cleaved caspase 9, a marker of fragmented nuclei during apoptosis, 
was performed (Zhu et al., 2012).  A greater proportion of MgaGT/GT embryos (7/9) had 
cleaved caspase 9-positive fragmented nuclei than did Mga+/+ and MgaGT/+ littermates 
(7/47) (p=0.012, Fisher’s Exact Probability test) (Fig 10A).  There was no difference in 
the proportion of Mga+/+ embryos with cleaved caspase 9-positive fragmented nuclei 
(3/20) compared to MgaGT/+ embryos (4/27) (p=1.00 Fisher’s Exact Probability test) 





Figure 10.  Apoptosis and cell proliferation at E4.5.  Numbers indicate the proportion of 
embryos showing the illustrated expression pattern. A. Immunofluorescence for cleaved 
caspase 9 shows that more MgaGT/GT embryos had fragmented nuclei than did Mga+/+ and 
MgaGT/+ embryos.  B.  Cell proliferation as measured by phosphorylated histone H3 
immunostaining was similar in MgaGT/GT compared to Mga+/+ and MgaGT/+ embryos.  C. 
Box plots of the number of phospho-histone H3-positive cells showed no difference 






Figure 11.  Cell cycle staging in the Epi of embryos at E4.5 A. MgaGT/+ embryo stained 
for phospho-histone H3.   Cell cycle stage can be determined by the pattern of phospho-
histone H3 staining.  Prophase nuclei show uniform staining (yellow arrowheads) 
compared to metaphase and anaphase nuclei, in which condensed chromatin staining is 
more punctate (red arrowheads).  B.  Box plots of the number of cells in meta/anaphase 
or prophase of mitosis.  There was no difference in the number of cells in prophase or 




incidence of apoptosis in MgaGT/GT embryos indicates a defect in the normal function of 
the cell leading to cell death rather than a defect in cell proliferation. 
  
Differentiation of primitive endoderm in MgaGT/GT embryos 
Structural integrity of MgaGT/GT embryos 
To test whether the structural integrity of MgaGT/GT embryos was intact, 
immunofluorescence with antibodies against E-cadherin was performed.  E-cadherin 
forms a thin layer around the compacted Epi and PrE with a thicker layer of staining in 
the basement membrane of the surrounding TE.  MgaGT/GT embryos had a similar staining 
pattern at E3.5 (n=4) and E4.5 (n=2) (Fig 12A, B) indicating that lethality was not the 
result of the embryo losing its structure. 
 
 Gene expression and pluripotency during the differentiation of the embryonic cell layers 
At E4.5, just prior to the time that MgaGT/GT embryos die, differentiation of the 
embryonic cell layers has begun.  The pluripotent ICM differentiates into two cell layers: 
the Epi remains pluripotent and becomes a compacted cell layer while the differentiated 
PE forms an epithelial sheet beneath it.  Immunofluorescence with antibodies against the 
pluripotency marker Nanog, which marks the Epi, and the PE marker Gata4 did not 
reveal any difference in the formation of cell layers between MgaGT/GT (n=3) and Mga+/+ 
or MgaGT/+ embryos (n=4) at E4.5 (Fig 12C, D). Immunofluorescence with antibodies 
against Oct4, a marker of pluripotency expressed in the Epi, did not generate sufficient 
signal to be analyzed, so an Oct4 GFP reporter  allele, Pou5f1tm2Jae (Lengner et al., 2007), 
was bred into the MgaGT background.  Immunofluorescence with anti-GFP antibodies 
showed a compacted Epi in both the Mga+/+ and MgaGT/+ embryos (n=27) and MgaGT/GT 
embryos (n=7) carrying the Pou5f1tm2Jae allele (Fig 12E, F).  Together, these results 
indicate that MgaGT/GT embryos showed disruption of the spatial and temporal gene 
expression normally characteristic of the differentiation of embryonic cell layers.  
Additionally, these results indicate that MgaGT/GT embryos do not lose expression of 





Figure 12.  Primitive endoderm differentiation in E4.5 embryos.  Numbers refer to the 
proportion of embryos showing the illustrated expression pattern.  A, B.  Optical sections 
of E4.5 embryos show that the E-Cadherin (red) staining pattern is similar in MgaGT/GT 
embryos and Mga+/+ and MgaGT/+ embryos.  C-F.  Projections of z-stacks show that 
Nanog (green C, D) and Oct4 as measured by GFP reporter (green E, F), markers of the 
pluripotent Epi, are similar in MgaGT/GT embryos compared to Mga+/+ and MgaGT/+ 





Maintenance of pluripotent cells in MgaGT/GT embryos 
 Despite the presence of pluripotency markers at E4.5, the death of the pluripotent 
cells of the Epi and its in vitro derivatives suggest that loss of pluripotent cell self-
maintenance could be responsible for the lethality of MgaGT/GT embryos.  To test 
maintenance of pluripotency in MgaGT/GT embryos, we examined embryos in which 
diapause was induced (Nichols et al., 2001). Diapause is a natural mechanism of delayed 
implantation of embryos in mothers who are still nursing a litter, and can be induced 
experimentally by hormone treatment.  During diapause, blastocysts do not implant in the 
uterus and Epi cells maintain pluripotency but do not undergo the cell proliferation and 
differentiation evident during normal development. 
 To determine whether Mga is expressed during diapause in normal embryos, RT-
PCR of pooled wild-type embryos was done.  One day after induction of diapause by 
tamoxifen and depo-provera injections at E2.5, Mga expression is at a level similar to 
E3.5 embryos before falling and being maintained a low level of expression at 4 days and 
7 days of diapause (Fig 13D).   
Immunofluorescence using antibodies against the pluripotency marker Nanog, 
present in the Epi, and the PE marker Gata4 was used to assess the persistence of cell 
populations throughout diapause.  In diapause embryos, similar to the situation in E4.5 
day embryos, the Epi forms a compacted group of cells overlying the PE.  One day after 
induction of diapause, MgaGT/GT embryos showed spatial gene expression patterns of 
Nanog and Gata4 that were identical to Mga+/+ and MgaGT/+ embryos.  The number of 
Nanog-expressing cells was similar in MgaGT/GT embryos (16.5 +/- 1.5) compared to 
Mga+/+ and MgaGT/+ embryos (13.7 +/- 1.2) (z = 1.17, p = 0.24 Mann-Whitney U test) 
(Table 3).  However, by 4 days after diapause induction, the number of Nanog-expressing 
cells in MgaGT/GT embryos (5.4 +/- 1.0) was smaller than Mga+/+ and MgaGT/+ embryos 
(18.1 +/- 0.9) (z = 3.240, p = 0.001) (Table 3).  The relative position and number of 
Gata4-expressing cells, however, was similar in in MgaGT/GT (21.9+/-2.8) compared to 
Mga+/+ and MgaGT/+ embryos (26.6+/-1.3)(z = 0.98, p = 0.33) (Fig 13A-C, Table 3).  By 
7 days after diapause induction, there were virtually no Nanog positive cells in MgaGT/GT 
embryoss (0.3+/-0.3 cells), while in Mga+/+ and MgaGT/+ embryo Nanog-positive cells 




Figure 13.  Loss of pluripotent cells during hormonally induced diapause.  A.  Nanog-
positive cells (green) are present initially, but are gradually lost during diapause in 
MgaGT/GT embryos.  Gata4-positive cells (red) persist longer but eventually disappear by 
E2.5+7 days.  B, C.  The number of Nanog-positive cells is significantly different in 
MgaGT/GT at 4 and 7 days of diapause (B), while Gata4-positive cells are significantly 
different only at 7 days of diapause (C).  “WT” refers to Mga+/+ and MgaGT/+ embryos. 
D.  One day after diapause is induced, RT-PCR indicates that in wild type embryos Mga 





Table 3.  Numbers of cells in differentiated cell layers in hormonally induced diapause 
embryos.  Nanog is a marker of pluripotent Epi and Gata4 is a marker of primitive 
endoderm.  Average number of cells and standard error were calculated on the indicated 
number of embryos. 
 
  
Time Genotype Nanog-positive cells Gata4-positive cells n (embryos) 
E2.5 + 1 
day 
Mga+/+ and 
MgaGT/+ 13.7 +/- 1.2 1 +/- 0.5 
7 
 
MgaGT/GT 16.5 +/- 1.5 0 +/- 0 2 
E2.5 + 4 
days 
Mga+/+ and 
MgaGT/+ 18.1 +/- 0.9 26.6 +/- 1.3 8 
MgaGT/GT 5.4 +/- 1.0 21.9 +/- 2.8 7 
E2.5 + 7 
days 
Mga+/+ and 
MgaGT/+ 12.6 +/- 1.4 35.7 +/- 2.4 7 
MgaGT/GT 0.3 +/- 0.3 6.7 +/- 0.9 3 
!!
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contrast to earlier time points, the number of Gata4-positive cells was also reduced in 
MgaGT/GT embryos (6.7+/-0.9) compared to Mga+/+ and MgaGT/+ embryos (35.7+/-2.4) 
(z=2.39, p-0.02) (Fig 13A-C, Table 3).  The Gata4-expressing cells appeared to have 
collapsed against the TE in the MgaGT/GT embryos.  Moreover, the mutant embryos had 
cells in the Epi that stained for neither Nanog nor Gata4 (Fig 13D).  While formation of 
embryonic cell layers occurs normally, the declining number of Epi cells in MgaGT/GT 
embryos during diapause implies that the pluripotent cells of the Epi are not properly 
maintained without Mga.  Conversely, the lack of an early effect on Gata4 expressing 
cells reflects a lack of requirement for Mga in PE differentiation.   
 
Regulation of downstream targets of Mga 
Expression of Myc-target gene Odc1 in MgaGT/GT embryos 
 After confirming proper structural integrity, cell layer differentiation, and 
pluripotency in MgaGT/GT embryos at E4.5, we utilized a candidate gene approach to 
assess downstream genetic effects of the Mga mutation (Table 4).  Odc1 (MGI: 97402, 
synonym Odc), the gene coding for ornithine decarboxylase (ODC), shows a similar 
expression pattern and embryonic mutant phenotype with Mga (Pendeville et al., 2001).  
ODC catalyzes the decarboxylation of ornithine to form putrescine, the rate-limiting step 
in the polyamine synthesis pathway for the production of spermine and spermidine (Fig 
14A).  In addition to the common embryonic phenotype it shares with Mga, Odc1 has 2 
E-box sites that have been shown to be able to bind bHLH-Zip domain family members 
including c-Myc and Mnt (Bello-Fernandez et al., 1993; Nilsson et al., 2004) (Fig 14B).   
 Immunofluorescence was performed on E4.5 embryos with antibodies against 
ODC.  Projections of confocal stacks showed decreased ODC signal in the Epi of 
MgaGT/GT embryos (4/6) at E4.5 compared to Mga+/+ and MgaGT/+ embryos (3/31) 
(p=0.006; Fisher’s Exact Probability test) (Fig 14C).  There was also strong signal on the 
exterior of the TE in all samples, though secondary antibody controls (data not shown) 






Table 4.  Candidate genes for Mga mutant analysis.  Candidate genes were chosen based 
on similar embryonic phenotype of homozygous mutants.  Of these candidates, the 
presence of E-box sites in a regulatory intron of Odc1 was unique.   
Gene Mutant Phenotype Reference 
Max Empty deciduae recovered after implantation, ICM failure 
in blastocyst culture 
(Shen-Li et al., 
2000) 
Klf5 Embryos not recovered after implantation, ectopic PE 
development 
(Lin et al., 2010) 
Notchless Empty deciduae recovered after implantation, ICM failure 
in blastocyst culture 
(Cormier et al., 
2006) 
CTCF Empty deicudea recovered after implantation, ICM failure 
in blastocyst culture 
(Moore et al., 
2012) 
Oct4 Empty deicudea recovered after implantation, ICM failure 
in blastocyst culture 
(Nichols et al., 
1998) 
Odc1 Empty deciduae recovered after implantation, ICM failure 







Figure 14.  Polyamine synthesis pathway and the expression of Ornithine Decarboxylase 
(ODC) in E4.5 embryos.  A.  ODC is the rate limiting step in the polyamine synthesis 
pathway that produces spermine and spermidine.  ODC catalyzes the conversion of 
ornithine to putrescine.  Putrescine is then converted into spermidine and spermine with 
the addition of decarboxylated S-adeonsyl-methionine (dcSAM).  B.  Two E-box binding 
sites (CACGTG) are evolutionarily conserved in the second intron.  Projections of 
confocal Z-stacks show lower levels of ODC (red) in the Epi of MgaGT/GT embryos at 




ICM growth in the presence of exogenous putrescine 
Decreased Odc1 expression in MgaGT/GT embryos suggests that embryos may lack 
the ability to produce putrescine and thus may lack the necessary end products of the 
polyamine synthesis pathway.  Putrescine deficiency caused by inhibition of ODC by the 
small molecule α-difluoromethylornithine (DFMO) can be alleviated by addition of 
exogenous putrescine to IE6 intestinal crypt cell cultures (Iwama et al., 1990).  Similarly, 
we attempted to rescue embryonic lethality in MgaGT/GT embryos by supplying exogenous 
putrescine to embryos.  Specifically, we supplemented blastocyst cultures with 200µM 
putrescine and measured the ICM outgrowths following 96 hours of culture, a time after 
which MgaGT/GT ICM outgrowths had been shown to be deficient in untreated cultures 
(Fig 8).   
 The surface area of the ICM outgrowth of MgaGT/GT blastocyst cultures was 
significantly larger when embryos were treated with putrescine (n=7) than when they 
were untreated (n=11) (t = -4.58, p = 0.0003) (Fig 15A, B).  The surface area of the ICM 
outgrowth in Mga+/+ and MgaGT/+ cultures, however, was similar with (n=29) or without 
putrescine (n=24) (t=1.4, p=0.18).   None of the treatments affected the outgrowth of 
trophoblast cells in culture. Notably, the ICM surface area of the putrescine-treated 
Mga+/+ or MgaGT/+ cultures (n=29) and MgaGT/GT cultures (n=11) was not significantly 
different (t = -1.83, p=0.08).  Morphologically, the ICM of treated mutants appeared to 
lack the 3-dimentional structural complexity that was present in Mga+/+ or MgaGT/+ 
cultures, though they still appeared larger than untreated MgaGT/GT cultures (Fig 15A).  
Together, these results indicate that exogenous putrescine is sufficient to at least partially 
rescue the ICM outgrowth of MgaGT/GT embryos.  
 
ES cell growth in the presence of exogenous putrescine 
The rescue of the ICM in blastocyst cultures with exogenous putrescine suggests 
that the ES cell survival defect of inversion-induced MgaInv/Inv; CreERT2 ES cells might 
also be rescued.  ES cells were plated in unsupplemented ES media and allowed to attach 
for 1 day.  Cultures were then given ES media that was either unsupplemented, contained 
tamoxifen to induce inversion, or contained both tamoxifen and 200µM putrescine.  




Figure 15. Blastocyst and ES cell culture with or without 200µM putrescine added.  A, B.  
ICM outgrowths of MgaGT/GT blastocyst cultures appeared larger when treated with 
putrescine for 4 days (A). ICM surface area after 4 days of culture of treated MgaGT/GT 
cultures was greater than untreated MgaGT/GT cultures and was not different from treated 
Mga+/+ or MgaGT/+ cultures (B).  C.  Greater numbers of MgaInv/Inv; CreERT2 ES cells 
that had inversion induced were present after 2 days of culture when treated with 




Cell counts from MgaInv/Inv; CreERT2 cultures treated with tamoxifen were higher 
when treated with putrescine than when untreated (t = 6.14; p <0.0001), but not as high as 
untreated MgaInv/Inv; CreERT2 ES cells (t = 3.17; p = 0.0036), suggesting that other 
factors may be required to compensate for the loss of Mga (Fig 15C).  Putrescine alone 
did not affect cell numbers in MgaInv/Inv; CreERT2 cells without tamoxifen, indicating 
that the rescue effect of exogenous putrescine is due to a deficiency in MgaInv/Inv; 
CreERT2 ES cells treated with tamoxifen rather than a general effect of the putrescine 
itself (t = -0.152, p = 0.88) (Fig 16A).   
To ensure that the rescue effect seen in MgaInv/Inv; CreERT2 cultures was specific 
to putrescine, MgaInv/Inv; CreERT2 cultures were treated with the structurally related 
cadaverine, another cationic polyamine that has an additional carbon-link in its backbone 
but is not part of the polyamine synthesis pathway.  Cadaverine treatment had no effect 
on MgaInv/Inv; CreERT2 cultures alone (t=-0.26, p=0.80) or on cultures that had inversion 
induced with tamoxifen (t = 0.05, p = 0.96) (Fig 16A).  
To control for the possibility that the rescue effect in MgaInv/Inv; CreERT2 was a 
result of interaction with CreERT2 or other ES cell components, MgaInv/+ ES cells and 
Mga+/+; CreERT2 ES cells were grown and treated with the chemical combinations 
described above.  Neither control cell lines showed any change in cell number with any 





Figure 16.  Box plots of cell counts of ES cell cultures treated with tamoxifen, putrescine, 
and cadaverine.  A-C.  MgaInv/Inv; CreERT2 (A), MgaInv/+(B), and Mga+/+; CreERT2 (C) 
ES cells were treated with the indicated chemicals for 48 hours before cells were counted.  
Scale indicates the percent of cells present compared to the average number of of the 







The importance of Mga in embryonic development 
 
We used a gene trap allele to assess the role of Mga during development 
(Schnutgen et al., 2005).  While this allele is not a knockout allele, we still have insight 
into its function.  The insertion of the gene trap cassette into the 3rd intron does not 
preclude transcription or translation of this allele; β-galactosidase activity in the embryo 
demonstrates that it is a functional reporter.  Furthermore, the reporter appears to be 
expressed in the same pattern as endogenous Mga as β-galactosidase activity is 
coincident with detection of the endogenous transcripts by RT-PCR.  MgaGT/GT embryos 
also have a defect in tissues where Mga transcripts are detected, notably the Epi 
derivatives (Yoshikawa et al., 2006).   The lack of a phenotype in MgaGT/+ embryos 
provides evidence that the mutant allele is not acting as a dominant negative in spite of 
the presence of the T-box in the fusion protein.  We thus consider the gene trap mutant 
allele MgaGT to be functionally equivalent to a null allele.   
Embryos with a homozygous loss of Mga fail to develop past E4.5 with 
embryonic death occurring during implantation.  The expression of Mga is restricted to 
the ICM of embryos at E3.5 and the Epi E4.5, implicating a failure of development of 
this tissue in the embryonic lethality of Mga mutants.  This hypothesis is supported by 
blastocyst cultures, which show Mga expression restricted to the ICM outgrowth and a 
failure of the ICM to expand during culture.  Moreover, ES cell culture of MgaInv/Inv; 
CreERT2 ES cells that had the conditional allele inverted to a mutant MgaRe-inv allele by 
tamoxifen formed smaller and sparser colonies with fewer total cells surviving.  Because 
complete inversion of both alleles was not seen in any cultures, it is likely that the deficit 
of surviving cells is a result of completely inverted, Mga mutant cells dying.   
 The loss of Mga leads to embryonic lethality by increasing the amount of 
apoptosis in the embryo.  Cleaved caspase 9, a marker of apoptosis, is more evident in 
MgaGT/GT than in Mga+/+ and MgaGT/+ embryos.  The rise in apoptosis is not accompanied 
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by a change in cell proliferation in the embryo.  Increased cell death of the Epi would 
explain both the stage of embryonic lethality as well as the presence of decidual swellings 
at the sites of implantation.  Because the TE is initially unaffected by the loss of Mga, the 
decidual reaction of the uterus would still proceed, leading to decidual swellings without 
intact embryos.  This phenotype has been noted in other mice that were mutant for ICM- 
or Epi-specific genes, notably Oct4 and Sox2 (Avilion et al., 2003; Nichols et al., 1998).             
 Because of the similar embryonic phenotype of mutants of Mga compared to 
mutants of genes associated with pluripotency, Oct4 and Sox2, we examined the 
expression of pluripotency markers at E4.5.  The Epi did not appear to lose pluripotency 
as gauged by expression of Oct4 and Nanog.  Additionally, the differentiation of PE was 
normal in Mga mutant embryos at E4.5 as gauged by expression of Gata4, as was 
differentiation of TE as judged by morphology.  Together, these data demonstrate that 
loss of Mga does not affect the early differentiation events in the embryo.  
To investigate whether pluripotency was maintained in Mga mutant embryos, we 
induced diapause to delay implantation.  Strikingly, we found that despite entering 
diapause with similar numbers of pluripotent cells, the number of Nanog-expressing Epi 
cells in Mga mutant embryos markedly decreases during continued delayed implantation.  
The number of differentiated, Gata-4 positive PE cells, by contrast, initially remains 
stable.  This suggests that the lack of Mga specifically affects the maintenance of the 
pluripotent cells, not the survival of differentiated cells, which do not initially require 
Mga to survive.  Death of differentiated cells later during diapause could be a secondary 
effect of the lack of Epi, as has been seen in other systems (Strumpf et al., 2005).   This 
effect is exacerbated in diapause when pluripotent cells are challenged in this way to 
maintain pluripotency for longer periods of time. 
Because pluripotent cells were dying without Mga, we used a candidate gene 
approach to identify possible factors responsible this effect.  We identified Odc1, the 
gene that codes for the polyamine synthesis enzyme ornithine decarboxylase based on the 
phenotypic similarity of the mouse mutants as well as the presence of E-box sites in its 
promoter (Bello-Fernandez et al., 1993; Pendeville et al., 2001).  Because Mga has been 
shown to bind E-box target sites, it was reasonable to propose that loss of Mga may have 
an effect on Odc. 
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We found that ODC was reduced in the Epi of E4.5 day Mga mutant embryos.  
Moreover, we found that culture with exogenous putrescine, the biochemical product of 
ODC activity, partially rescued cell survival defects in both the Epi outgrowths of 
blastocyst cultures as well as those in ES cell culture.  This suggests that one of the main 
roles of Mga in the preimplantation development of the embryos is to regulate the 
transcription of Odc1, an enzyme critical for the polyamine synthesis pathway.  More 
generally, it suggests that Mga plays a crucial role in the survival of pluripotent cell 
populations not by regulating pluripotency itself, but rather by ensuring that cellular 
metabolism is functional.    
 
The role of polyamines in embryonic development 
 
Mice deficient for components of the polyamine synthesis pathway have shown 
that polyamines have an important role in peri-implantation development.  Odc1 mutant 
mice fail to develop due to a defect in the growth of the ICM during implantation 
(Pendeville et al., 2001).  Knockout of Amd1, a crucial enzyme for the production of 
spermine and spermidine (Fig 12A) also leads to embryonic lethality at the same time.  
Amd1-mutant blastocysts fail to form an ICM outgrowth in blastocyst cultures, 
implicating failure of ICM development as the cause of embryonic lethality (Nishimura et 
al., 2002) and suggesting a general role for polyamines in regulating the survival of the 
ICM and Epi.  The importance of polyamines in preimplantation development is reflected 
in our own findings that embryos lacking the necessary components for the synthesis of 
polyamines cannot develop properly.    
Synthetic disruption of Odc1 function was also found to affect pluripotent cells in 
vitro.  Inactivation of Odc1 with DFMO in F9 teratocarcinoma cell cultures leads to a 
decrease in the total number of cells when counted 2 days later.  Moreover, cells that did 
grow were differentiated, suggesting a role for Odc1 in the maintenance of pluripotent 
cell populations (Frostesjo et al., 1997).  On the other hand, overexpression of Odc1 
promoted self-renewal of ES cells in the absence of LIF.  Odc1 also increased the 
efficiency of iPS cell generation in the absence of c-Myc (Zhao et al., 2012).   
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Besides ODC itself, other components of the polyamine synthesis pathway have 
also been linked to survival of pluripotent cell populations.  Knockdown of Amd1 leads to 
a loss of pluripotency markers and differentiation of ES cultures.  Moreover, addition of 
exogenous spermine to the cultures rescues this defect (Zhang et al., 2012).  Together, 
this highlights the importance of ODC in the function of pluripotent cells, a finding that 
our results support. 
The necessity of polyamines for peri-implantation development could be 
explained in a number of ways.  The first is that the polyamine synthesis pathway is 
required to generate intermediates for other biological processes, such as DNA 
methylation.  The methylation of cytosine, a critical step during preimplantation 
development, involves the incorporation of a methyl group from S-adenosyl-methionine 
(SAM) through the action of DNA MTase (Fig 14A).  This enzyme is inhibited by high 
levels of decarboxylated S-adenosylmethionine (dcAdoMet), a reactant in the production 
of spermine and spermidine.  It is possible that in the absence of putrescine, dcAdoMet 
accumulates and DNA methylation cannot occur.  Indeed, synthetic inhibition of ODC 
with DFMO leads to a decrease in the amount of DNA methylation in teratocarcinoma 
cells (Frostesjo et al., 1997).  Disruption of SAM production leading to preimplantation 
embryonic lethality is supported by the finding that deletion of S-andeosylhomocysteine 
hydrolase (Ahcy) a key synthetic enzyme for the production of SAM, leads to inhibition 
of ICM growth (Miller et al., 1994).  Further studies to assess the DNA methylation state 
of Mga mutant embryos or ES cells would shed light on this possible mechanism of 
action. 
Another possible explanation for the importance of polyamines in development is 
that they regulate the expression of genes important for progression through the cell 
cycle.  Unbalancing the polyamine pool by inhibiting ODC with DFMO leads to a 
decrease in the expression of c-Myc in cancer cell lines.   The addition of spermidine to 
the cultures, however, restores normal levels of c-Myc expression (Celano et al., 1988).  
The decrease in c-Myc leads to an increase in the amount of p21Cip1 transcription, a 
critical necessary for cell cycle progression (Liu et al., 2006).  In the mouse model of 
familial adenomatous polyposis (FAP), polyamine pools are also unbalanced, though in 
this case through overexpression of Odc1 in the small intestine and colon.  Synthetic 
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inhibition of ODC in this model alleviates the cancer phenotype, indicating that the 
proper balance of polyamines is critical for normal proliferation control (Erdman et al., 
1999).  Further experiments assessing the transcription of downstream genes in rescued 
blastocyst culture or ES cell cultures could assess whether the Mga-mediated depletion of 
ODC and disregulation of polyamine pools leads to a loss of control of the cell cycle.  
The role of Mga in the regulation of c-Myc transcription and Max network protein 
function in cancer could also be explored by breeding the Mga mutant allele into mouse 
models of cancer, specifically the APCmin mouse that models FAP or other c-Myc mutants 
that model cancer, such as the Eµ-myc mouse model of hematocarcinomas (Adams et al., 
1985; Erdman et al., 1999).   
Polyamines have also been shown to be important for regulating translation in 
cultured mammalian cells.  HeLa cells transfected with SAT1, which codes for the 
catabolic protein SAT1 that is responsible for degrading polyamines by acetylating 
spermine and spermidine, had a decrease in the production of endogenous proteins and 
subsequent cell growth arrest.  This decrease was not accompanied by any decrease in the 
synthesis of DNA or RNA indicating a post-transcriptional mechanism of gene regulation 
(Mandal et al., 2013).  It is possible that decreasing the stores of polyamines by 
decreasing the expression of Odc1 would lead to a lack of translation and subsequent 
growth arrest during embryonic development.   
A final explanation for the importance of polyamines in peri-implantation 
development could be that the downstream products of the polyamine synthesis pathway 
are needed for regulating normal cell cycle progression rather than the polyamines 
themselves.  Genetic profiling of lymphoma samples identified Amd1 and eiF5a as 
common mutations leading to cancer (Scuoppo et al., 2012).  These lymphomas had a 
deficit of hypusinated-eIF5A, a direct product of polyamine synthesis.  Further 
experiments testing the presence of products of the polyamine synthesis pathway such as 
hypusine could shed light on how the loss of ODC affects the polyamine pool in mutant 
embryos or ES cells.  Alternately, experiments using the downstream products of the 
polyamine synthesis pathway to rescue embryos could elucidate which products are 





The interaction of Mga and c-Myc 
 
 The finding that Mga has a regulatory effect on the expression of Odc1 is 
somewhat surprising given a large body of work demonstrating that c-Myc   regulates the 
expression of Odc1 (Bello-Fernandez et al., 1993; Pendeville et al., 2001).  However, a 
closer examination of the Max network’s transcriptional targets provides insight into how 
Mga might play a role in the regulation of Odc1 or other E-box targets.  It is possible, for 
example, that Mga and c-Myc compete for available E-box binding sites.  Alternately, it 
is possible that Mga and c-Myc compete for available Max, the obligate 
heterodimarization partner that allows these genes to bind DNA.   
 Mga has been shown to directly compete with c-Myc for E-box binding in in vitro 
assays.  Co-transfection of c-Myc with Max in HEK293 cells leads to an increase in 
transcription of a luciferase reporter driven by an E-box promoter.  This effect is 
abrogated by co-transfection with increasing concentrations of Mga plasmid.  A similar 
result is seen in primary rat fibroblasts, in which transfection with Mga suppresses c-Myc 
and Ras-mediated transformation (Hurlin et al., 1999).  The interaction of Max-network 
members in gene regulation is seen in other systems as well.  In neuroblastomas, Mga 
expression correlates positively with Odc1 expression.  There is, however, no correlation, 
when samples that have normal N-myc levels rather than N-myc amplifications are 
considered.  The fact that variable levels of N-myc can modulate the activity of Mga 
indicates that Max network proteins are able to regulate the activities of the entire Max 
network and that changing the cellular levels of any one of these components can have 
effects on the activities of the others (Geerts et al., 2010).    
 One explanation for the effects of Mga on the other Max-network proteins is 
competition for Max binding between proteins of the network.  Because Max is necessary 
for bHLHZip proteins to bind DNA, only the set of bHLHZip proteins that can access 
Max will be active.  The limited cellular stores of Max can only accommodate a finite 
number of interactions with other Max-network proteins, and by changing the 
concentration of one of the proteins, it is feasible that others can access newly available 
Max, or that Max homodimerization becomes favored.  Max-network proteins have been 
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shown to alter the functions of one another when co-expressed in Cos cells (Grinberg et 
al., 2004), so it is a reasonable hypothesis that this is happening embryonically. 
 Another explanation for the effects that Mga has on putative c-Myc regulated E-
box targets is the broad ability of Max-network proteins to bind the canonical E-box.  
Mnt, for example, has been shown to bind to promoters of multiple genes that are 
considered c-Myc targets during cell growth but not during quiescence, including notably 
Odc1 (Nilsson et al., 2004; Popov et al., 2005).  This type of context dependency has 
been shown with other members of the Max network (Xu et al., 2001; Zervos et al., 
1993).  It is possible that the Odc1 promoter is regulated by Mga in the context of the 
peri-implantation embryo, but by other Max-network proteins in other contexts.  
Alternately, c-Myc may serve to amplify transcription of Odc1 after induction of 
transcription by Mga.  This notion is supported by the fact that in human colon carcinoma 
cells and intestinal epithelial cells, c-Myc transcription has been shown to be dependent 
on ODC function.  In these studies, ODC must be produced before c-Myc transcription 
begins; it is possible that another factor such as Mga could be responsible for initial Odc1 
transcription with c-Myc amplifying transcription later (Celano et al., 1988; Liu et al., 
2006).  c-Myc acting as an amplifier of transcription of Odc1 rather than the as the 
transcriptional initiator is supported by the role that c-Myc plays in the global 
amplification of transcription in ES cells (Lin et al., 2012).   
 
 
A model for the role of Mga during embryonic development 
 
Combined with previous work on the Max network of transcription factors, our 
results suggest a possible mechanism for Mga to play a critical role in peri-implantation 
development of the embryo.  Mga may interact with other proteins in the Max network, 
notably c-Myc, to regulate transcription of Odc1.  In the absence of Mga, Odc1 is 
downregulated and end products of the polyamine synthesis pathway necessary for the 
ICM to develop are not produced in sufficient amounts.  Further experiments can provide 
insight into the mechanism of polyamine-depletion-mediated failure of the ICM, though 
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loss of control of the cell cycle and subsequent apoptosis seems a likely mechanism based 




 One of the most interesting findings of our studies is the necessity of Mga in the 
survival of pluripotent tissues.  While it is clear that these cells do not survive in the 
absence of Mga, whether they still retain the differentiation capacity of pluripotent cells 
before their death is not clear.  It is possible that the cell death is a result of a loss of 
pluripotency.  This can be addressed in a number of ways.   
First, ES cells lacking Mga could be differentiated into embryoid bodies.  Some 
initial work has already been done towards this aim.  To ensure that tamoxifen treatment 
of MgaInv/Inv; CreERT2 ES cells does not affect the differentiation of these ES cells and 
that the ES cells do not differentiate in the presence of residual MgaInv alleles that have 
not yet undergone inversion, MgaRe-inv/Re-inv; CreERT2 ES cells were generated by 
tamoxifen treatment of MgaInv/Inv; CreERT2 cells in the presence of putrescine.  Single 
colonies were picked and expanded to generate two subclones that completely lacked 
Mgainv alleles.  These ES cells are able to generate EBs in the absence of putrescine, 
indicating that Mga is not necessary for differentiation, or for survival of differentiated 
cells.  It is unclear, though, whether these ES cells are able to survive long enough with 
residual putrescine from ES culture to differentiate before no longer needing putrescine 
as differentiated cells.  More detailed studies of the differentiation of these ES cell lines 
that have had putrescine removed from the media at earlier time points could shed light 
on this issue.     Furthermore, it is unclear whether the EBs formed contain differentiated 
tissue from all 3 embryonic germ layers.  A more detailed analysis of the EBs including 
embryonic marker analysis could answer this question.   
Another way to assess the differentiation capacity of cells lacking Mga is to 
induce differentiation in the ICM of putrescine-rescued MgaGT/GT embryos in culture.  
Preliminary studies have been performed culturing E3.5 ICMs that were separated from 
the surrounding TE by immunosurgery to induce differentiation to PE.  These studies 
have shown that without putrescine rescue, mutant ICMs are not able to differentiate into 
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PE while rescued ICM are, though in reduced numbers compared to Mga+/+ or MgaGT/+ 
ICMs.  It is unclear whether this descrepency is a result of fewer ICM cells surviving 
despite the presence of putrescine or of a deficiency in the differentiation capacity of 
MgaGT/GT ICMs.  Marker or transcriptional analysis of rescued ICMs could reveal a defect 
in the pluripotency transcriptional program that is distinct from the defect in polyamine 
synthesis.   
The importance of Mga in the transcription of Odc1 also raises the possibility that 
other polyamine synthesis genes are also not transcribed in MgaGT/GT embryos.  Srm, the 
gene responsible for synthesizing spermine, for example, has multiple E-box regulatory 
sequences in its promoter and may be regulated by Mga (Forshell et al., 2010).  This is 
supported by preliminary experiments that have shown that exogenous spermine is 
sufficient to rescue ICM outgrowth in MgaGT/GT blastocyst cultures.  There are two 
possible explanations for this result: the first is that Mga is needed to transcribe Srm, and 
that exogenous spermine is able to compensate for the lack of Srm in making spermine.  
The second possibility is that embryos without Mga are not producing spermine because 
of lack of ODC function and the subsequent lack of putrescine.  Exogenous spermine 
may bypass the need for putrescine by supplying the spermine that cannot be made in the 
absence of putrescine.  Immunofluorescence for these components could shed light on the 
presence or absence of other components of the polyamine synthesis pathway.  
Alternately, assaying the levels of polyamines could shed light on whether exogenous 
putrescine is being converted to spermine in MgaGT/GT cultures, or whether MgaGT/GT 
embryos lack components of the polyamine synthesis pathway other than ODC necessary 
for the production of the final polyamines.   
The deregulation of polyamines and their downstream products in the progression 
of a number of different cancers is also interesting.  As Mga is able to affect the 
polyamine pools by regulating the expression of Odc1, it makes an interesting target for 
studies in cancer models.  Specifically, the conditional MgaInv allele could be bred into 
the mouse model of human APC.  This model has increased expression of Odc1 and its 
cancerous phenotype is abrogated by synthetic inhibition of ODC.  According to this 
possible model, Mga mutation would slow the progression of tumorogenesis by 




Materials and Methods 
 
Mutant alleles 
Mice carrying the Mouse Genome Informatics (MGI) allele MgaGt(E153E01)Wrst  
were obtained from the German Gene Trap Consortium and alleles derived from it were 
used in these studies. In the following, the alleles are referred to as MgaGT (for gene trap), 
MgaInv (for FLP-recombinase inverted gene trap) or MgaRe-inv (for Cre-recombinase re-
inverted gene trap). ES cell clones were isolated from E14Tg2a ES cells (Sv129P2) after 
retroviral infection using rsFlpRosaβgeo (FlpRBG; www.genetrap.de). The insertion of 
FlpRBG in intron 3 of Mga was identified by splinkerette PCR (Horn et al., 2007).   
 
Mice and genotyping 
Mga mutant mice were obtained from the German Gene Trap Consortium.  
Analysis of adult mice and embryos was performed on an random bred ICR background 
(Taconic Farms, Germantown, NY).  Offspring were counted at weaning and ear punches 
or tail tips were digested in PBND lysis buffer (50 mM KCl, 10mM Tris-HCl, 
(pH8.3), 2.5mM MgCl2-6H2O, 0.1 mg/mL gelatin, 0.45% NP4,0 0.45% Tween20) with 
100ug/mL Proteinase K (Roche 03115801001) for PCR genotyping.  Mice carrying the 
MgaGT allele were genotyped using a three-primer PCR protocol designed to amplify 
wildtype and mutant bands using primers AJW360, AJW363, and AJW365.  Mice 
carrying the MgaInv  allele were genotyped using primers AJW360, AJW363, and 
AJW236.  MgaRe-inv/+ were genotyped using primers AJW360, AJW363, and AJW366.  
MgaRe-inv/Inv mice were genotyped with AJW360, AJW366, and AJW236 (see table 2 in 
this chapter).  PCR conditions were 4 minutes at 95oC, 32 cycles of 30 seconds at 95 oC, 
30 seconds at 61 oC, and 40 seconds at 72C, and 5 minutes at 72C.  PCR was performed 
using 2.5uM dNTPs, 1X PCR Buffer (Denville CB3702-7), 1M Betaine [Sigma B2629], 
2.5uM primers, and taq that had been prepared in-house previously. 
Embryos were generated and collected from timed matings using a vaginal plug 
as 0.5 days post coitus (defined as E0.5).  After analysis, embryos were lysed in 15uL of 
lysis buffer (10mM Tris pH7.5, 10mM EDTA, 100mM NaCl, 0.5% Sarcosyl, 100ug/mL 
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Proteinase K) at 55°C for 2 hours and analyzed by genotyping using primers AJW360, 
AJW363, and AJW365 with Herculase II polymerase (Agilent 600675) according to 
manufacturer’s guidelines with 1M betaine added. 
 
RT-PCR 
E0.5 wild type embryos were collected from the oviduct followed by treatment 
with acid tyrodes solution (Sigma T1788) to remove the zona pellucida.  E2.5, 3.5, and 
4.5 embryos were collected by uterine flushing using M2 media (Sigma M7167-100mL).  
For RT-PCR, 42 E0.5 embryos, 26 E2.5, 35 E3.5, and 29 E4.5 embryos were pooled.  
RNA was isolated using a RNeasy mini kit (Qiagen 74104) and RT-PCR was performed 
using a OneStep RT-PCR kit (Qiagen 210212) as described, with primers AJW346 and 
AJW349 for Mga and AJW371 and AJW372 for β-actin. 
 
β-galactosidase activity assay  
Embryos were generated from Mga+/+ x MgaGT/+ crosses.  E3.5 and E4.5 embryos 
were collected by uterine flushing using M2 media and E5.5, E6.5, and E7.5 embryos by 
isolating individual deciduae and manually dissecting embryos in cold PBS with 0.1% 
bovine serum albumin (Sigma A9647-50g).  Embryos were fixed for 20 minutes in 4% 
paraformaldehyde at 4°C and then washed 3 times quickly in PBS with 0.1% Tween20 
(Fischer BP337-500).   
For whole mount staining, embryos were then incubated in X-Gal staining buffer 
(1mg/mL 5-Bromo-4-chloro-3-indolyl β-D-galactopyranoside in dimethyl sulfoxide 
[Sigma B4352], 20mM K4Fe, 20mM K3Fe, 2mM MgCl2 in PBS) overnight at 37C.  
Embryos were then washed 3 times in PBS with 0.1% Tween and fixed in 4% 
paraformaldehyde before being photographed. 
For cryosectioning, embryos were transferred to 20% sucrose overnight and then 
embedded in O.C.T. Compound (Tissue-Tek 4583).  10-12µm sections were cut and 
dried and slides were fixed in 4% paraformaldehyde for 10 minutes at 4°C and incubated 
in X-Gal staining buffer overnight at 37°C.  Slides were fixed in 4% paraformaldehyde 
and then counterstained with Eosin Y (Sigma 318906-500mL) and mounted in Permount 
(Fisher SP15-500) before photographing. 
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For greater sensitivity, Salmon-Gal was used to confirm expression patterns 
(Sundararajan et al., 2012).  Embryos were flushed with M2 and fixed briefly at 4C with 
4% PFA.  Embryos were washed twice with S-Gal rinse solution (0.1% sodium 
deoxycholate, 0.2% IGEPAL (Sigma I8896), 2mM MgCl2 and 0.1 M phosphate buffer 
pH 7.3).  Embryos were then incubated with 1mg/ml Salmon Gal (6-chloro-3-indolyl-B-
D-galactopyranoside, Lab Scientific X668) and 6µg/ml NBT (4-nitro blue tetrazolium 
chloride, Sigma N6876) dissolved in 70% N, N-dimethylformamide in water at 37C for 1 
or more days.   
 
Blastocyst outgrowth in vitro 
Embryos were generated from MgaGT/+ x MgaGT/+ crosses and collected at E3.5 
by uterine flushing using M2 media.  Zona pellucidae were removed by incubation in 
acid tyrodes solution for approximately 2 minutes at room temperature.  Embryos were 
then plated on tissue culture dishes (BD Falcon 353003) in 20µL drop of ES media 
(DMEM [Gibco 11965-092], 13% FBS [Hyclone Cat #SH30071.03 Lot #ARG27092], 
1% Pen/Strep [Gibco 15070], 1% GlutaMax [Gibco 35050-061], 1% Sodium Pyruvate 
[Gibco 11360-070], 1% Non-Essential Amino Acids [Gibco 11140-050], 0.1% Beta-
Mercaptoethanol [Gibco 21985-023], LIF derived from CHO cells in-house) and covered 
in mineral oil (Fischer 0122-1).  Embryos were cultured at 37°C in 5% CO2 in air 
(Bhatnagar et al., 1995).  Cultures were photographed daily and the surface area of the 
ICM and trophoblast was assessed by morphology and quantitated using ImageJ (NIH, 
http://rsb.info.nih.gov/ij/).   
For rescue experiments, embryos were cultured in ES media with 200uM 
putrescine (Sigma P5780-5g) dissolved in water.  Following culture, embryos were 
scraped off of the dish and genotyped.   
 
Immunohistochemistry 
Embryos were generated from MgaGT/+ x MgaGT/+ crosses and collected by uterine 
flushing using M2 media.  Immunohistochemistry was performed as previously described 
(Artus et al., 2010).  Briefly, embryos were cultured in DMEM/HEPES (Gibco 12430-
054) and 10% FBS (Hyclone Cat #SH30071.03 Lot #ARG27092) for 20 minutes at 37°C 
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and 5% CO2 and then fixed in 4% paraformaldehyde with 0.1% Tween20 and 0.01% 
TritonX (Fischer BP151-500) for 10 minutes at room temperature or overnight at 4C.  
Embryos were then washed in PBT (PBS with 0.1% TritonX) before permeabilization 
with 0.5% TritonX for 20 minutes at room temperature.  After 3x 5 minute washes with 
PBT, antigens were unmasked with NH4Cl (Sigma A-4514) in PBT for 10 minutes at 
room temperature.  Following 2x 5 minutes washes, embryos were blocked in 2% donkey 
serum in PBT for 45 minutes at room temperature.  Embryos were then incubated with 
the first primary antibodies overnight at 4°C in 2% donkey serum.  The following day, 
embryos were washed 3 times with PBT and incubated with the second primary antibody 
overnight at 4°C in 2% donkey serum.  The following day, embryos were washed 3 times 
with PBT and incubated with secondary antibodies overnight at 4°C in the dark.  
Embryos were again washed 3 times with PBT and incubated with Hoecst 33342 (Sigma 
B2261) diluted 1:500 overnight at 4°C in the dark.  Embryos were washed 2 more times 
and then analyzed using a Nikon A1R confocal microscope and NIS Elements v4.0 
software with MatTek 35mm petri dishes with coverglass (MatTek P35G-0-10-C).  
Embryos were then lysed and genotyped with Herculase II polymerase.  Statistics were 
analyzed using Fisher’s exact probability test.   
 
Embryonic diapause and immunosurgery  
Diapause was induced in pregnant females at E2.5 by subcutaneous injection of 
3mg Depo Provera suspended in PBS (Medroxyprogesterone 17-acetate Sigma M1629-
1g) and intraperitoneal injection of 20µg tamoxifen in sunflower seed oil (Sigma T5648-
1g).  Embryos were then flushed from the uterus with M2 1-7 days later. 
To perform immunosurgery, embryos were washed twice with Hams F12 media (Gibco 
11765-054) and incubated in 20% rabbit anti-mouse serum antibody (Sigma M5774) in 
Hams F12 for 30 minutes at 37°C in 7% CO2 in air.  Embryos were washed 3 times in 
Hams F12 before incubation with 20% guinea pig compliment (CalBiochem 234395) in 
Hams F12 with 1:100 Propidium Iodide (Sigma P4864) and 1:100 Hoechst 33342.  
Embryos were washed quickly 3 times in Hams F12 and squashed on a glass slide with a 
glass coverslip before being photographed on a Nikon fluorescent microscope with NIS 
Elements software.   
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Immunohistochemistry was performed as described, though the embryos 
remained intact allowing PCR genotyping after imaging.  Statistics were analyzed using 
Fisher’s exact probability test and Mann-Whitney U test.     
 
ES Cells 
MgaInv/Inv; CreERT2 and MgaInv/+ ES cell lines were derived using previously 
established protocols (Batlle-Morera et al., 2008).  Embryos were generated from 
MgaInv/Inv; CreERT2 x MgaInv/+; CreERT2 matings and diapause was induced at E2.5.  
Embryos were flushed with M2 4 days after diapause induction.  Immunosurgery was 
performed as described and isolated ICMs were plated on gelatin-coated tissue culture 
dishes in mES media supplemented with recombinant human BMP4 (R&D Systems 314-
BP-010) and MEK inhibitor PD98059 (Cell Signalling Technology 9900S).  After 7-10 
days, ICM outgrowths were trypsinized with 0.25% trypsin (Gibco 25200-056) and 
replated on mitomycin-C (Sigma M4287) treated MEFs.  Inversion was induced using 4-
hydroxytamoxifen (Sigma H6278).  “Inverted” cultures were treated with 200µM 
putrescine and 200µM cadaverine (Sigma D22606) dissolved in water.  For cell count 
assays, cells were counted and then plated in separate wells, allowed, to attach over night, 
and then treated the next day. After 48 hours of chemical treatment, cells were 
trypsinized and counted on a hemocytometer in duplicate or triplicate and the counts 
averaged.  Statistics were analyzed using a Student’s t-test.   
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Table 1 – Primer sequences 
 













Table 2 – Primer combinations for genotyping 
Genotypes tested Primer Combination 
Mga+/+, MgaGT/+, MgaGT/GT AJW360/AJW363/AJW365 









Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., 
Cory, S., Palmiter, R. D. and Brinster, R. L. (1985). The c-myc oncogene 
driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic 
mice. Nature 318, 533-538. 
Arnold, S. J., Hofmann, U. K., Bikoff, E. K. and Robertson, E. J. (2008). Pivotal roles 
for eomesodermin during axis formation, epithelium-to-mesenchyme transition 
and endoderm specification in the mouse. Development 135, 501-511. 
Artus, J., Panthier, J. J. and Hadjantonakis, A. K. (2010). A role for PDGF signaling 
in expansion of the extra-embryonic endoderm lineage of the mouse blastocyst. 
Development 137, 3361-3372. 
Avilion, A. A., Nicolis, S. K., Pevny, L. H., Perez, L., Vivian, N. and Lovell-Badge, R. 
(2003). Multipotent cell lineages in early mouse development depend on SOX2 
function. Genes & development 17, 126-140. 
Ayer, D. E., Kretzner, L. and Eisenman, R. N. (1993). Mad: A heterodimeric partner 
for Max that antagonizes Myc transcriptional activity. Cell 72, 211-222. 
Batlle-Morera, L., Smith, A. and Nichols, J. (2008). Parameters influencing derivation 
of embryonic stem cells from murine embryos. Genesis 46, 758-767. 
Baudino, T. A. and Cleveland, J. L. (2001). The Max network gone mad. Molecular 
and cellular biology 21, 691-702. 
Bello-Fernandez, C., Packham, G. and Cleveland, J. (1993). The ornithine 
decarboxylase gene is a transcriptional target  of c-Myc. Proc. Natl. Acad. Sci. 
USA 90, 7804-7808. 
Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, 
B., Meissner, A., Wernig, M., Plath, K., et al. (2006). A bivalent chromatin 
structure marks key developmental genes in embryonic stem cells. Cell 125, 315-
326. 
Bhatnagar, P., Papaioannou, V. E. and Biggers, J. D. (1995). CSF-1 and mouse 
preimplantation development in vitro. Development 121, 1333-1339. 
Blelloch, R., Venere, M., Yen, J. and Ramalho-Santos, M. (2007). Generation of 
Induced Pluripotent Stem Cells in the Absence of Drug Selection. Cell Stem Cell 
1, 245-247. 
Bollag, R. J., Siegfried, Z., Cebra-Thomas, J. A., Garvey, N., Davison, E. M. and 
Silver, L. M. (1994). An ancient family of embryonically expressed mouse genes 
sharing a conserved protein motif with the T locus. Nature genetics 7, 383-389. 
Brenner, R., Slayden, O., Rodgers, W., Critchley, H., Carroll, R., Jing Nie, X. and 
Mah, K. (2003). Immunocytochemical assessment of mitotic activity with an 
antibody to phosphorylated histone H3 in the macaque and human endometrium. 
Human Reproduction 18, 1185-1193. 
Celano, P., Baylin, S. B., Giardiello, F. M., Nelkin, B. D. and Casero, R. A., Jr. 
(1988). Effect of polyamine depletion on c-myc expression in human colon 
carcinoma cells. The Journal of biological chemistry 263, 5491-5494. 
Chapman, D. L., Garvey, N., Hancock, S., Alexiou, M., Agulnik, S. I., Gibson-
Brown, J. J., Cebra-Thomas, J., Bollag, R. J., Silver, L. M. and Papaioannou, 
!!
58!
V. E. (1996). Expression of the T-box family genes, Tbx1–Tbx5, during early 
mouse development. Developmental Dynamics 206, 379-390. 
Chazaud, C., Yamanaka, Y., Pawson, T. and Rossant, J. (2006). Early lineage 
segregation between epiblast and primitive endoderm in mouse blastocysts 
through the Grb2-MAPK pathway. Dev Cell 10, 615-624. 
Cormier, S., Le Bras, S., Souilhol, C., Vandormael-Pournin, S., Durand, B., Babinet, 
C., Baldacci, P. and Cohen-Tannoudji, M. (2006). The murine ortholog of 
notchless, a direct regulator of the notch pathway in Drosophila melanogaster, is 
essential for survival of inner cell mass cells. Molecular and cellular biology 26, 
3541-3549. 
Davenport, T. G., Jerome-Majewska, L. A. and Papaioannou, V. E. (2003). 
Mammary gland, limb and yolk sac defects in mice lacking Tbx3, the gene 
mutated in human ulnar mammary syndrome. Development 130, 2263-2273. 
Davis, A., Wims, M., Spotts, G., Hann, S. and Bradley, A. (1993). A null c-myc 
mutation causes lethality before 10.5 days of gestation in homozygotes and 
reduced fertility in heterozygous female mice. Genes & development 7, 671-682. 
de Luca, C., Kowalski, T. J., Zhang, Y., Elmquist, J. K., Lee, C., Kilimann, M. W., 
Ludwig, T., Liu, S. M. and Chua, S. C., Jr. (2005). Complete rescue of obesity, 
diabetes, and infertility in db/db mice by neuron-specific LEPR-B transgenes. The 
Journal of clinical investigation 115, 3484-3493. 
Domashenko, A., Latham, K. and Hatton, K. (1997). Expression of myc-family, myc-
interacting,  and myc-target Genes During Preimplantation  Mouse Development. 
Molecular Reproduction and Development 47, 57-65. 
Downs, K. M., Martin, G. R. and Bishop, J. M. (1989). Contrasting patterns of myc 
and N-myc expression during gastrulation of the mouse embryo. Genes & 
development 3, 860-869. 
Dubois, N. C., Adolphe, C., Ehninger, A., Wang, R. A., Robertson, E. J. and 
Trumpp, A. (2008). Placental rescue reveals a sole requirement for c-Myc in 
embryonic erythroblast survival and hematopoietic stem cell function. 
Development 135, 2455-2465. 
Erdman, S., Ignatenko, N., Powell, M., Blohm-Mangone, K., Holubec, H., Guillen-
Rodriguez, J. and Gerner, E. (1999). APC-dependent changes in expression of 
genes influencing polyamine metabolism, and consequences for gastrointestinal 
carcinogenesis, in the Min mouse. Carcinogenesis 20, 1709-1713. 
Forshell, T. P., Rimpi, S. and Nilsson, J. A. (2010). Chemoprevention of B-Cell 
Lymphomas by Inhibition of the Myc Target Spermidine Synthase. Cancer 
Prevention Research 3, 140-147. 
Frostesjo, L., Holm, I., Grahn, B., Page, A. W., Bestor, T. H. and Heby, O. (1997). 
Interference with DNA methyltransferase activity and genome methylation during 
F9 teratocarcinoma stem cell differentiation induced by polyamine depletion. The 
Journal of biological chemistry 272, 4359-4366. 
Geerts, D., Koster, J., Albert, D., Koomoa, D.-L. T., Feith, D. J., Pegg, A. E., 
Volckmann, R., Caron, H., Versteeg, R. and Bachmann, A. S. (2010). The 
polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict 
aggressive behavior in neuroblastomas with and without MYCN amplification. 
International Journal of Cancer 126, 2012-2024. 
!!
59!
Gibson-Brown, J. J., Agulnik, S. I., Silver, L. M., Niswander, L. and Papaioannou, 
V. E. (1998). Involvement of T-box genes Tbx2-Tbx5 in vertebrate limb 
specification and development. Development 125, 2499-2509. 
Grandori, C., Cowley, S. m., James, L. p. and Eisenman, R. N. (2000). The 
Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev 
Cell Dev Biol 16, 653. 
Greulich, F., Rudat, C. and Kispert, A. (2011). Mechanisms of T-box gene function in 
the developing heart. Cardiovascular Research 91, 212-222. 
Grinberg, A. V., Hu, C.-D. and Kerppola, T. K. (2004). Visualization of 
Myc/Max/Mad Family Dimers and the Competition for Dimerization in Living 
Cells. Molecular and cellular biology 24, 4294-4308. 
Habets, P., Moorman, A., Clout, D., van Roon, M., Lingbeek, M., van Lohuizen, M., 
Campione, M. and Christoffels, V. (2002). Cooperative action of Tbx2 and 
Nkx2.5 inhibits ANF expression in the atrioventricular canal: implications for 
cardiac chamber formation. Genes & development 16, 1234-1246. 
Hamatani, T., Carter, M. G., Sharov, A. A. and Ko, M. S. H. (2004). Dynamics of 
Global Gene Expression Changes during Mouse Preimplantation Development. 
Developmental cell 6, 117-131. 
Hammachi, F., Morrison, Gillian M., Sharov, Alexei A., Livigni, A., Narayan, S., 
Papapetrou, Eirini P., O'Malley, J., Kaji, K., Ko, Minoru S. H., Ptashne, M., 
et al. (2012). Transcriptional Activation by Oct4 Is Sufficient for the Maintenance 
and Induction of Pluripotency. Cell Reports 1, 99-109. 
Han, J., Yuan, P., Yang, H., Zhang, J., Soh, B. S., Li, P., Lim, S. L., Cao, S., Tay, J., 
Orlov, Y. L., et al. (2010). Tbx3 improves the germ-line competency of induced 
pluripotent stem cells. Nature 463, 1096-1100. 
Hancock, S. N., Agulnik, S. I., Silver, L. M. and Papaioannou, V. E. (1999). Mapping 
and expression analysis of the mouse ortholog of Xenopus Eomesodermin. 
Mechanisms of Development 81, 205-208. 
Hayward, W. S., Neel, B. G. and Astrin, S. M. (1981). Activation of a cellular onc gene 
by promoter insertion in ALV-induced lymphoid leukosis. Nature 290, 475-480. 
Horn, C., Hansen, J., Schnutgen, F., Seisenberger, C., Floss, T., Irgang, M., De-Zolt, 
S., Wurst, W., von Melchner, H. and Noppinger, P. R. (2007). Splinkerette 
PCR for more efficient characterization of gene trap events. Nature genetics 39, 
933-934. 
Hu, G., Kim, J., Xu, Q., Leng, Y., Orkin, S. H. and Elledge, S. J. (2009). A genome-
wide RNAi screen identifies a new transcriptional module required for self-
renewal. Genes & development 23, 837-848. 
Hurlin, P., Steingrimsson, E., Copeland, N., Jenkins, N. and Eisenman, R. (1999). 
Mga, a dual-specificity transcription factor that interacts with Max and contains a 
T-domain DNA-binding motif. The EMBO journal 18, 7019-7028. 
Hurlin, P. J. and Huang, J. (2006). The MAX-interacting transcription factor network. 
Seminars in cancer biology 16, 265-274. 
Hurlin, P. J., Queva, C., Koskinen, P. J., Steingrimsson, E., Ayer, D. E., Copeland, 
N. G., Jenkins, N. A. and Eisenman, R. N. (1995). Mad3 and Mad4: novel Max-
interacting transcriptional repressors that suppress c-myc dependent 
!!
60!
transformation and are expressed during neural and epidermal differentiation. The 
EMBO journal 14, 5646-5659. 
Illingworth, R. S., Botting, C. H., Grimes, G. R., Bickmore, W. A. and Eskeland, R. 
(2012). PRC1 and PRC2 Are Not Required for Targeting of H2A.Z to 
Developmental Genes in Embryonic Stem Cells. PLoS ONE 7, e34848. 
Ivanova, N., Dobrin, R., Lu, R., Kotenko, I., Levorse, J., DeCoste, C., Schafer, X., 
Lun, Y. and Lemischka, I. R. (2006). Dissecting self-renewal in stem cells with 
RNA interference. Nature 442, 533-538. 
Iwama, K., Wang, J.-Y., Jain, R., Shirley., M. and Leonard., J. (1990). Intestinal 
ornithine decarboxylase- half-life and regulation by putrescine. Am. J. Physiol 
258, G308-G315. 
Jedrusik, A., Parfitt, D. E., Guo, G., Skamagki, M., Grabarek, J. B., Johnson, M. H., 
Robson, P. and Zernicka-Goetz, M. (2008). Role of Cdx2 and cell polarity in 
cell allocation and specification of trophectoderm and inner cell mass in the 
mouse embryo. Genes & development 22, 2692-2706. 
Johnson, M. H. and McConnell, J. M. L. (2004). Lineage allocation and cell polarity 
during mouse embryogenesis. Seminars in Cell & Developmental Biology 15, 
583-597. 
Kim, J., Chu, J., Shen, X., Wang, J. and Orkin, S. H. (2008). An Extended 
Transcriptional Network for Pluripotency of Embryonic Stem Cells. Cell 132, 
1049-1061. 
Kispert, A. and Herrmann, B. G. (1993). The Brachyury gene encodes a novel DNA 
binding protein. The EMBO journal 12, 3211-3220. 
Lardelli, M. (2003). The evolutionary relationships of zebrafish genes tbx6, 
tbx16/spadetail and mga. Dev Genes Evol 213, 519-522. 
Lengner, C. J., Camargo, F. D., Hochedlinger, K., Welstead, G. G., Zaidi, S., 
Gokhale, S., Scholer, H. R., Tomilin, A. and Jaenisch, R. (2007). Oct4 
expression is not required for mouse somatic stem cell self-renewal. Cell Stem 
Cell 1, 403-415. 
Lin, Charles Y., Lovén, J., Rahl, Peter B., Paranal, Ronald M., Burge, 
Christopher B., Bradner, James E., Lee, Tong I. and Young, Richard A. 
(2012). Transcriptional Amplification in Tumor Cells with Elevated c-Myc. Cell 
151, 56-67. 
Lin, S. C., Wani, M. A., Whitsett, J. A. and Wells, J. M. (2010). Klf5 regulates lineage 
formation in the pre-implantation mouse embryo. Development 137, 3953-3963. 
Liu, L., Guo, X., Rao, J. N., Zou, T., Marasa, B. S., Chen, J., Greenspon, J., Casero, 
R. A., Jr. and Wang, J. Y. (2006). Polyamine-modulated c-Myc expression in 
normal intestinal epithelial cells regulates p21Cip1 transcription through a 
proximal promoter region. The Biochemical journal 398, 257-267. 
Loh, Y.-H., Wu, Q., Chew, J.-L., Vega, V. B., Zhang, W., Chen, X., Bourque, G., 
George, J., Leong, B., Liu, J., et al. (2006). The Oct4 and Nanog transcription 
network regulates pluripotency in mouse embryonic stem cells. Nature genetics 
38, 431-440. 
Lu, R., Yang, A. and Jin, Y. (2011). Dual functions of T-box 3 (Tbx3) in the control of 
self-renewal and extraembryonic endoderm differentiation in mouse embryonic 
stem cells. The Journal of biological chemistry 286, 8425-8436. 
!!
61!
Malynn, B. A., de Alboran, I. M., O'Hagan, R. C., Bronson, R., Davidson, L., 
DePinho, R. A. and Alt, F. W. (2000). N-myc can functionally replace c-myc in 
murine development, cellular growth, and differentiation. Genes & development 
14, 1390-1399. 
Mandal, S., Mandal, A., Johansson, H. E., Orjalo, A. V. and Park, M. H. (2013). 
Depletion of cellular polyamines, spermidine and spermine, causes a total arrest 
in translation and growth in mammalian cells. Proceedings of the National 
Academy of Sciences of the United States of America 110, 2169-2174. 
Meroni, G., Cairo, S., Merla, G., Messali, S., Brent, R., Ballabio, A. and Reymond, 
A. (2000). Mlx, a new Max-like bHLHZip family member: the center stage of a 
novel transcription factors regulatory pathway? Oncogene 19, 3266-3277. 
Meroni, G., Reymond, A., Alcalay, M., Borsani, G., Tanigami, A., Tonlorenzi, R., Lo 
Nigro, C., Messali, S., Zollo, M., Ledbetter, D. H., et al. (1997). Rox, a novel 
bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, 
binds a non-canonical E box and acts as a transcriptional repressor. The EMBO 
journal 16, 2892-2906. 
Mesbah, K., Harrelson, Z., Theveniau-Ruissy, M., Papaioannou, V. E. and Kelly, R. 
G. (2008). Tbx3 is required for outflow tract development. Circulation research 
103, 743-750. 
Miller, M. W., Duhl, D. M., Winkes, B. M., Arredondo-Vega, F., Saxon, P. J., Wolff, 
G. L., Epstein, C. J., Hershfield, M. S. and Barsh, G. S. (1994). The mouse 
lethal nonagouti (a(x)) mutation deletes the S-adenosylhomocysteine hydrolase 
(Ahcy) gene. The EMBO journal 13, 1806-1816. 
Mitsui, K., Tokuzawa, Y., Itoh, H., Segawa, K., Murakami, M., Takahashi, K., 
Maruyama, M., Maeda, M. and Yamanaka, S. (2003). The homeoprotein 
Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. 
Cell 113, 631-642. 
Moore, J. M., Rabaia, N. A., Smith, L. E., Fagerlie, S., Gurley, K., Loukinov, D., 
Disteche, C. M., Collins, S. J., Kemp, C. J., Lobanenkov, V. V., et al. (2012). 
Loss of Maternal CTCF Is Associated with Peri-Implantation Lethality of 
<italic>Ctcf</italic> Null Embryos. PLoS ONE 7, e34915. 
Murphy, M. J., Wilson, A. and Trumpp, A. (2005). More than just proliferation: Myc 
function in stem cells. Trends in cell biology 15, 128-137. 
Naiche, L. A., Harrelson, Z., Kelly, R. G. and Papaioannou, V. E. (2005). T-box 
genes in vertebrate development. Annual review of genetics 39, 219-239. 
Nichols, J., Chambers, I., Taga, T. and Smith, A. (2001). Physiological rationale for 
responsiveness of mouse embryonic stem cells to gp130 cytokines. Development 
128, 2333-2339. 
Nichols, J., Zevnik, B., Anastassiadis, K., Niwa, H., Klewe-Nebenius, D., Chambers, 
I., Scholer, H. and Smith, A. (1998). Formation of pluripotent stem cells in the 
mammalian embryo depends on the POU transcription factor Oct4. Cell 95, 379-
391. 
Nie, Z., Hu, G., Wei, G., Cui, K., Yamane, A., Resch, W., Wang, R., Green, D. R., 
Tessarollo, L., Casellas, R., et al. (2012). c-Myc is a universal amplifier of 
expressed genes in lymphocytes and embryonic stem cells. Cell 151, 68-79. 
!!
62!
Nilsson, J. A., Maclean, K. H., Keller, U. B., Pendeville, H., Baudino, T. A. and 
Cleveland, J. L. (2004). Mnt loss triggers Myc transcription targets, proliferation, 
apoptosis, and transformation. Molecular and cellular biology 24, 1560-1569. 
Nishimura, K., Nakatsu, F., Kashiwagi, K., Ohno, H., Saito, T. and Igarashi, K. 
(2002). Essential role of S-adenosylmethionine decarboxylase in mouse 
embryonic development. Genes to Cells 7, 41-47. 
Ogawa, H., Ishiguro, K., Gaubatz, S., Livingston, D. M. and Nakatani, Y. (2002). A 
Complex with Chromatin Modifiers That Occupies E2F- and Myc-Responsive 
Genes in G0 Cells. Science (New York, N.Y.) 296, 1132-1136. 
Papapetrou, C., Edwards, Y. H. and Sowden, J. C. (1997). The T transcription factor 
functions as a dimer and exhibits a common human polymorphism Gly-177-Asp 
in the conserved DNA-binding domain. FEBS letters 409, 201-206. 
Paynton, B. V., Rempel, R. and Bachvarova, R. (1988). Changes in state of 
adenylation and time course of degradation of maternal mRNAs during oocyte 
maturation and early embryonic development in the mouse. Developmental 
biology 129, 304-314. 
Pendeville, H., Carpino, N., Marine, J. C., Takahashi, Y., Muller, M., Martial, J. A. 
and Cleveland, J. L. (2001). The Ornithine Decarboxylase Gene Is Essential for 
Cell Survival during Early Murine Development. Molecular and cellular biology 
21, 6549-6558. 
Plusa, B., Piliszek, A., Frankenberg, S., Artus, J. and Hadjantonakis, A.-K. (2008). 
Distinct sequential cell behaviours direct primitive endoderm formation in the 
mouse blastocyst. Development 135, 3081-3091. 
Popov, N., Wahlstrom, T., Hurlin, P. J. and Henriksson, M. (2005). Mnt 
transcriptional repressor is functionally regulated during cell cycle progression. 
Oncogene 24, 8326-8337. 
Rikin, A. and Evans, T. (2010). The tbx/bHLH transcription factor mga regulates gata4 
and organogenesis. Developmental Dynamics 239, 535-547. 
Russ, A. P., Wattler, S., Colledge, W. H., Aparicio, S. A. J. R., Carlton, M. B. L., 
Pearce, J. J., Barton, S. C., Surani, M. A., Ryan, K., Nehls, M. C., et al. 
(2000). Eomesodermin is required for mouse trophoblast development and 
mesoderm formation. Nature 404, 95-99. 
Sawai, S., Shimono, A., Hanaoka, K. and Kondoh, H. (1991). Embryonic lethality 
resulting from disruption of both N-myc alleles in mouse zygotes. The New 
biologist 3, 861-869. 
Sawai, S., Shimono, A., Wakamatsu, Y., Palmes, C., Hanaoka, K. and Kondoh, H. 
(1993). Defects of embryonic organogenesis resulting from targeted disruption of 
the N-myc gene in the mouse. Development 117, 1445-1455. 
Schnutgen, F., De-Zolt, S., Van Sloun, P., Hollatz, M., Floss, T., Hansen, J., 
Altschmied, J., Seisenberger, C., Ghyselinck, N. B., Ruiz, P., et al. (2005). 
Genomewide production of multipurpose alleles for the functional analysis of the 
mouse genome. Proceedings of the National Academy of Sciences of the United 
States of America 102, 7221-7226. 
Schreiber-Agus, N., Horner, J., Torres, R., Chiu, F. C. and DePinho, R. A. (1993). 
Zebra fish myc family and max genes: differential expression and oncogenic 
!!
63!
activity throughout vertebrate evolution. Molecular and cellular biology 13, 
2765-2775. 
Scuoppo, C., Miething, C., Lindqvist, L., Reyes, J., Ruse, C., Appelmann, I., Yoon, 
S., Krasnitz, A., Teruya-Feldstein, J., Pappin, D., et al. (2012). A tumour 
suppressor network relying on the polyamine-hypusine axis. Nature 487, 244-248. 
Shen-Li, H., O'Hagan, R., Harry Hou Jr, H., James Horner II, J., H-W., H.-W. L. 
and DePinho, R. (2000). Essential role for Max in early embryonic growth and 
development. Genes & development 14, 17-22. 
Showell, C., Binder, O. and Conlon, F. L. (2004). T-box genes in early embryogenesis. 
Developmental dynamics : an official publication of the American Association of 
Anatomists 229, 201-218. 
Silva, J., Nichols, J., Theunissen, T. W., Guo, G., van Oosten, A. L., Barrandon, O., 
Wray, J., Yamanaka, S., Chambers, I. and Smith, A. (2009). Nanog is the 
gateway to the pluripotent ground state. Cell 138, 722-737. 
Sinha, S., Abraham, S., Gronostajski, R. M. and Campbell, C. E. (2000). Differential 
DNA binding and transcription modulation by three T-box proteins, T, TBX1 and 
TBX2. Gene 258, 15-29. 
Stanton, B. R., Perkins, A. S., Tessarollo, L., Sassoon, D. A. and Parada, L. F. 
(1992). Loss of N-myc function results in embryonic lethality and failure of the 
epithelial component of the embryo to develop. Genes & development 6, 2235-
2247. 
Strumpf, D., Mao, C. A., Yamanaka, Y., Ralston, A., Chawengsaksophak, K., Beck, 
F. and Rossant, J. (2005). Cdx2 is required for correct cell fate specification and 
differentiation of trophectoderm in the mouse blastocyst. Development 132, 2093-
2102. 
Sundararajan, S., Wakamiya, M., Behringer, R. R. and Rivera-Perez, J. A. (2012). 
A fast and sensitive alternative for beta-galactosidase detection in mouse 
embryos. Development 139, 4484-4490. 
Takahashi, K. and Yamanaka, S. (2006). Induction of Pluripotent Stem Cells from 
Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors. Cell 126, 
663-676. 
Tanaka, T. S., Kunath, T., Kimber, W. L., Jaradat, S. A., Stagg, C. A., Usuda, M., 
Yokota, T., Niwa, H., Rossant, J. and Ko, M. S. (2002). Gene expression 
profiling of embryo-derived stem cells reveals candidate genes associated with 
pluripotency and lineage specificity. Genome research 12, 1921-1928. 
Teo, A. K., Arnold, S. J., Trotter, M. W., Brown, S., Ang, L. T., Chng, Z., 
Robertson, E. J., Dunn, N. R. and Vallier, L. (2011). Pluripotency factors 
regulate definitive endoderm specification through eomesodermin. Genes & 
development 25, 238-250. 
van den Berg, D. L. C., Snoek, T., Mullin, N. P., Yates, A., Bezstarosti, K., Demmers, 
J., Chambers, I. and Poot, R. A. (2010). An Oct4-Centered Protein Interaction 
Network in Embryonic Stem Cells. Cell Stem Cell 6, 369-381. 
Varlakhanova, N. V., Cotterman, R. F., deVries, W. N., Morgan, J., Donahue, L. R., 
Murray, S., Knowles, B. B. and Knoepfler, P. S. (2010). myc maintains 
embryonic stem cell pluripotency and self-renewal. Differentiation; research in 
biological diversity 80, 9-19. 
!!
64!
Walker, W., Zhou, Z. Q., Ota, S., Wynshaw-Boris, A. and Hurlin, P. J. (2005). Mnt-
Max to Myc-Max complex switching regulates cell cycle entry. The Journal of 
cell biology 169, 405-413. 
Washkowitz, A. J., Gavrilov, S., Begum, S. and Papaioannou, V. E. (2012). Diverse 
functional networks of Tbx3 in development and disease. Wiley interdisciplinary 
reviews. Systems biology and medicine 4, 273-283. 
Xu, D., Popov, N., Hou, M., Wang, Q., Bjorkholm, M., Gruber, A., Menkel, A. R. 
and Henriksson, M. (2001). Switch from Myc/Max to Mad1/Max binding and 
decrease in histone acetylation at the telomerase reverse transcriptase promoter 
during differentiation of HL60 cells. Proceedings of the National Academy of 
Sciences of the United States of America 98, 3826-3831. 
Yoshikawa, T., Piao, Y., Zhong, J., Matoba, R., Carter, M. G., Wang, Y., Goldberg, 
I. and Ko, M. S. H. (2006). High-throughput screen for genes predominantly 
expressed in the ICM of mouse blastocysts by whole mount in situ hybridization. 
Gene Expression Patterns 6, 213-224. 
Zeller, K., Jegga, A., Aronow, B., O'Donnell, K. and Dang, C. (2003). An integrated 
database of genes responsive to the Myc oncogenic transcription factor: 
identification of direct genomic targets. Genome Biology 4, R69. 
Zervos, A. S., Gyuris, J. and Brent, R. (1993). Mxi1, a protein that specifically 
interacts with Max to bind Myc-Max recognition sites. Cell 72, 223-232. 
Zhang, D., Zhao, T., Ang, H. S., Chong, P., Saiki, R., Igarashi, K., Yang, H. and 
Vardy, L. A. (2012). AMD1 is essential for ESC self-renewal and is 
translationally down-regulated on differentiation to neural precursor cells. Genes 
& development 26, 461-473. 
Zhao, T., Goh, K. J., Ng, H. H. and Vardy, L. A. (2012). A role for polyamine 
regulators in ESC self-renewal. Cell cycle (Georgetown, Tex.) 11, 4517-4523. 
Zhu, Q., Jin, L., Casero, R. A., Davidson, N. E. and Huang, Y. (2012). Role of 
ornithine decarboxylase in regulation of estrogen receptor alpha expression and 








Additional publications produced in the course of doctoral research: 
 
 
1. Medioni, C., et al. (2010). "Expression of Slit and Robo genes in the developing 
mouse heart." Dev Dyn 239(12): 3303-3311. 
 
2. Washkowitz, A. J., et al. (2012). "Diverse functional networks of Tbx3 in 









a PATTERNS & PHENOTYPES
Expression of Slit and Robo Genes in the
Developing Mouse Heart
Caroline Medioni,1† Nicolas Bertrand,2† Karim Mesbah,3 Bruno Hudry,3 Laurent Dupays,4
Orit Wolstein,5 Andrew J. Washkowitz,6 Virginia E. Papaioannou,6 Timothy J. Mohun,4
Richard P. Harvey,5,7 and Ste´phane Zaffran2*
Development of the mammalian heart is mediated by complex interactions between myocardial, endocar-
dial, and neural crest-derived cells. Studies in Drosophila have shown that the Slit-Robo signaling path-
way controls cardiac cell shape changes and lumen formation of the heart tube. Here, we demonstrate by
in situ hybridization that multiple Slit ligands and Robo receptors are expressed in the developing mouse
heart. Slit3 is the predominant ligand transcribed in the early mouse heart and is expressed in the ven-
tral wall of the linear heart tube and subsequently in chamber but not in atrioventricular canal myocar-
dium. Furthermore, we identify that the homeobox gene Nkx2-5 is required for early ventral restriction of
Slit3 and that the T-box transcription factor Tbx2 mediates repression of Slit3 in nonchamber myocar-
dium. Our results suggest that patterned Slit-Robo signaling may contribute to the control of oriented
cell growth during chamber morphogenesis of the mammalian heart. Developmental Dynamics 239:3303–
3311, 2010. VC 2010 Wiley-Liss, Inc.
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INTRODUCTION
Cardiogenesis is one of the earliest
and most critical steps during verte-
brate organogenesis. Heart develop-
ment begins when cardiac progenitor
cells in the anterior lateral mesoderm
cluster in the primary heart field
(Harvey, 2002). These cells give rise
to the cardiac crescent and linear
heart tube containing the future left
ventricle and atrioventricular canal
(AVC; see Buckingham et al., 2005).
Subsequently the heart tube under-
goes rightward looping (Harvey,
2002). As looping progresses, cells of
the second heart field in splanchnic
mesoderm are added to the heart tube
to form the outflow tract (OFT), right
ventricle, atria and inflow tract
regions (Buckingham et al., 2005).
Subsequently, atrial and ventricular
chambers form through a localized
process that involves differential
growth or ‘‘ballooning’’ of the outer cur-
vature of the heart tube (Christoffels
et al., 2000). Importantly, part of the
heart tube, including the OFT, inner
curvature, AVC, and inflow tract,
escapes this developmental chamber
program through the repressive action
of the T-box factors, Tbx2 and Tbx3
(Habets et al., 2002; Christoffels et al.,
2004b; Harrelson et al., 2004; Bakker
et al., 2008). Regionalized gene expres-
sion provides evidence for the presence
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of dorsoventral patterning in the early
tube that precedes chamber develop-
ment (Christoffels et al., 2004a). A ret-
rospective clonal analysis of cardiac
cells has shown that myocardium, from
the time of its formation, is a polarized
and regionalized tissue in which ori-
ented cell growth may be important in
shaping the chambers (Meilhac et al.,
2004). Although key factors that play a
role in forming the heart tube have
been identified, including GATA4,
NKX2-5, dHAND, TBX5, or RALDH2
(Harvey, 2002), the molecular effectors
of cell polarity and cell shape changes
remain unknown.
The extracellular-matrix molecule
Slit and its Robo (roundabout) family
receptors have been implicated in the
regulation of cell polarity and morpho-
genesis during formation of the cardiac
tube in Drosophila (Qian et al., 2005;
MacMullin and Jacobs, 2006; Medioni
et al., 2008; Santiago-Martinez et al.,
2008). In particular, the Slit-Robo path-
way is required for progressive polar-
ization of cardiac cells during migra-
tion to the midline (Medioni et al.,
2008). In contrast to the single Slit and
three Robo genes in Drosophila, three
distinct Slit genes (Slit1, Slit2, and
Slit3) and four distinct Robo genes
(Robo1, Robo2, Rig1/Robo3, and
Robo4) are found in mammals (Chedo-
tal, 2007). Slit functions as a repulsive
ligand for the Robo-family receptors in
the central nervous system (CNS), and
acts both attractively and repulsively
in somatic muscles (Kidd et al., 1998,
1999; Brose et al., 1999; Simpson et al.,
2000; Wu et al., 2001). In addition,
both gene families display distinct
expression patterns outside the CNS
(Holmes et al., 1998; Yuan et al., 1999;
Strickland et al., 2006). Remarkably,
Slit3 is widely expressed in different
organs, including the tongue, kidney,
pharynx, umbilical cord vein, heart,
lung, and diaphragm (Yuan et al.,
1999; Liu et al., 2003; Yuan et al.,
2003). Consistent with its expression
in non-neural tissues, studies have
established that Slit3 is required for
angiogenesis and formation of the dia-
phragm and kidney (Liu et al., 2003;
Yuan et al., 2003; Zhang et al., 2009).
The role of the Drosophila Slit-Robo
pathway in regulating changes in cell
shape during cardiac tube formation
prompted us to conduct a detailed
analysis of murine Slit and Robo gene
expression during mouse heart devel-
opment. We describe that Slit3 in par-
ticular, shows a specific localization in
the ventral region of the forming
heart tube and subsequently restric-
tion to chamber myocardium. We
show that the homeobox gene Nkx2-5
is required for the ventral restriction
of Slit3 in the linear heart tube. In
addition, we demonstrate that the T-
box factors Tbx2 and Tbx20 mediate
the restriction of Slit3 expression to
the chamber myocardium. Given the
spatial and temporal expression pro-
file of Slit3 and its role in polarized
growth and migration in other tis-
sues, we propose that Slit-Robo sig-
naling may be required for cardiac
chamber expansion.
RESULTS AND DISCUSSION
Expression of Mouse Slit and
Robo Genes During Heart
Development
Previous studies in Drosophila have
shown that the Slit-Robo signaling
pathway controls cardiac cell polarity
and formation of the cardiac lumen
(Medioni et al., 2009). Therefore, we
decided to analyze the expression pat-
tern of murine Slit and Robo genes in
the developing heart. In contrast to
other tissues, detailed analysis of the
cardiac expression pattern of Slit and
Robo genes has not been reported
(Holmes et al., 1998; Yuan et al., 1999;
Holmes and Niswander, 2001; Liu et al.,
2003; Yuan et al., 2003). Mouse embryos
between 7.5 and 12.5 days of develop-
ment (E7.5–E12.5) were hybridized
with antisense riboprobes for Slit1,
Slit2, Slit3, Robo1, Robo2, Rig1/Robo3,
and Robo4 (Figs. 1, 2; also see Supp.
Fig. S1, which is available online).
Fig. 1. Expression pattern of Slit genes during embryonic heart development. Whole-mount in situ hybridization analysis of embryos with Slit1
(A–D), Slit2 (E–H), and Slit3 (I–L) probes. A: Ventral view of embryonic day (E) 8.5 embryo showing Slit1 expression in the ventral midline (arrow-
head). Slit1 is not detected in the forming heart tube. B: Lateral view of E9 embryo showing Slit1 expression in the roof plate (arrowhead), in the
floor plate (double arrowhead), and the pharyngeal region (white arrows). B0: Frontal section (same embryo depicted in B) showing Slit1 expression
in the mesodermal core of the pharyngeal arch (white arrows) and in the floor plate of the spinal cord. C: High magnification picture of heart at
late E9.5 showing Slit1 in atrial wall. D: Dissected E12.5 heart showing no expression of Slit1. D0: In situ hybridization with Slit1 on section of
E12.5 heart. E: Slit2 was not detected in the heart of embryo at E8.5 stage. Note its expression at the ventral midline (arrowhead). F: Lateral view
of early E9.5 embryo showing Slit2 expression in the pharyngeal region (asterisk). Slit2 is also detected in the roof plate (arrowhead), the noto-
chord (double arrowheads) and the somites (white arrowhead). F0: Frontal section (same embryo depicted in F) showing Slit2 expression in the
pharyngeal ectoderm surface (arrows). G: Dissected E9.5 heart showing no expression of Slit2. H: A robust expression of Slit2 is detected in tra-
beculae of both ventricles at E12.5. H0: In situ hybridization on section of E12.5 heart shows expression in the trabeculae (arrowhead). I,I0: Ventral
views of E7.5 and E8.5 embryos showing Slit3 expression in the cardiac crescent and the forming heart tube. Expression of Slit3 is also detected
in the ventral midline (black arrowhead) and the somites (white arrowhead) of E8.5 embryo. J: Lateral view of early E9.5 embryo showing Slit3
expression in the heart and the pharyngeal ectoderm surface (asterisk) and in the somites (white arrowhead). J0: Frontal section (same embryo
depicted in J) showing expression of Slit3 in pharyngeal ectoderm surface (arrows). K: High magnification picture of the heart at late E9.5. Expres-
sion of Slit3 is seen in the outflow tract, the atria and ventricles of the embryonic heart. L: At E12.5, expression of Slit3 is maintained in the right
and left atria and in great arteries, the aorta and pulmonary trunk. L0: Section of the heart shown in L. ao, aorta; cc, cardiac crescent; ht, heart
tube; la, left atrium; lv, left ventricle; oft, outflow tract; pt, pulmonary trunk; ra; right atrium; rv, right ventricle.
Fig. 2. Expression pattern of Robo genes during embryonic heart development. Whole-mount in situ hybridization analysis of embryos with
Robo1 (A–D) and Robo2 (E–H) probes. A: Ventral view of early embryonic day (E) 8.5 embryo showing Robo1 expression in the venous pole (white
arrows) of the forming heart tube. B: Lateral view of early E9 embryo. Robo1 expression is detected in the notochord (double arrowhead), the
somites (white arrowhead), and the ectodermal pouches of the pharyngeal arches (asterisk) but not in the heart. C: High magnification picture of
the heart at late E9.5 showing Robo1 in the cushions (asterisk) of the outflow tract. D: Dissected E12.5 heart showing expression of Robo1 at the
base of the great arteries (arrow). E: Ventral view of early E8.5 embryo. High Robo2 expression levels are visible in the neural tube and the venous
pole (white arrows) of the forming heart tube. F: Lateral view of E9.5 embryo. Weak expression of Robo2 is detected in the looped heart, the ecto-
derm of the pharyngeal arches (asterisk) and the notochord (double arrowheads). G: High magnification of the heart at E10.5 showing Robo2 in
both atria. H: Dissected E12.5 heart showing expression of Robo2 in the great arteries (arrowheads). ht, heart tube; la, left atrium; lv, left ventricle;
oft, outflow tract; ra; right atrium; rv, right ventricle.




































During this period of development,
Slit1 expression was primarily
observed in the roof plate and the floor
plate (Fig. 1A,B). Slit1 transcripts were
also observed in the mesodermal core
of the pharyngeal arches (Fig. 1B,B0).
Interestingly, pharyngeal mesoderm
has been shown to contribute to the for-
mation of the OFT as well as the pha-
ryngeal arch artery (PAA) development
(see Kelly and Buckingham, 2002). At
E9.5, Slit1 expression was detected in
the developing heart in the left and
right atria (Fig. 1C). However, at E12.5
we did not observe any expression in
the heart (Fig. 1D,D0).
Similarly to Slit1, Slit2 expression
was observed prominently in neural
tissue (Fig. 1E,F). From E8.5 to E9.5,
Slit2 expression was not detected in
the myocardium; however, it was
highly expressed in the pharyngeal
region at these stages (Fig. 1F) as
reported by others (Yuan et al., 1999;
Calmont et al., 2009). Strong expres-
sion of Slit2 was seen in the pharyn-
geal surface ectoderm (Fig. 1F0). This
tissue has been shown to be a crucial
source of signals for fourth PAA for-
mation and remodeling (Kirby, 2007).
Slit2 has also been identified as a
downstream target of Tbx1, and is
implicated in cardiac neural crest
cells (NCC) migration at the time of
PAA formation (Calmont et al., 2009).
While no clear expression in the em-
bryonic heart was detected at E9.5
(Fig. 1G), a strong expression of Slit2
was observed in the trabecular region
of the ventricular chambers at E12.5
(Fig. 1H,H0). Of interest, the trabecu-
lar formation occurs when cardiomyo-
cytes migrate toward the endocar-
dium, which is coincident with up-
regulation of cell adhesion molecules
(Ong et al., 1998). Thus, our observa-
tion suggests that other cell signaling
molecules such as Slit may be
involved in this process.
Slit3 is the earliest Slit gene to be
expressed in the developing heart.
Transcripts were observed in the car-
diac crescent at E7.5 and in the linear
heart tube at E8.5 (Fig. 1I,I0). At E8.5,
Slit3 expression is observed on the
ventral wall of the linear heart tube
(see Fig. 3A,B). Slit3 is also expressed
in the ventral midline and developing
somites (Fig. 1I,J). Unlike the other
Slit genes, Slit3 expression was
observed in all compartments of em-
bryonic heart at E9.5, restricted to
the outer curvature of the looped
heart (Fig. 1J,K). The myocardium of
the outer curvature is known to give
rise to the ventricular chamber or
‘‘working’’ myocardium (de la Cruz
and Markwald, 1999; Christoffels
et al., 2000). Analysis of the distribu-
tion of clonally related myocytes has
demonstrated that different patterns
of oriented cell growth underlie re-
gional differences in morphogenesis
within the embryonic heart (Meilhac
et al., 2004). The expression pattern
of Slit3 and its established role in
polarized growth and migration in
other tissues suggest implication of
Slit-Robo signaling in the oriented
cell growth that accompanies balloon-
ing of the ventricular chambers
(Christoffels et al., 2004a). By E12.5,
expression of Slit3 was observed only
in myocardium of the atria and at the
base of the great arteries (Fig. 1L,L0),
in agreement with published expres-
sion data (Liu et al., 2003). Remark-
ably, expression of Slit2 and Slit3 in
ventricular chambers seem to be com-
plementary in the endocardium and
myocardium respectively. This observa-
tion suggests requirement of a specific
Slit ligand during trabeculae formation.
Despite that difference, Slit2 and Slit3
were detected in the surface pharyn-
geal ectoderm of embryo at E9.5 (Fig.
1F,F0,J,J0), suggesting redundancy of
these molecules during cardiac NCC
migration and PAA formation. The Slit-
Robo signaling pathway is known to be
involved in trunk neural crest migra-
tion (Jia et al., 2005). It would be inter-
esting to identify whether Slit-Robo sig-
naling mediates repulsive or attractive
signals during cardiac NCCmigration.
Robo family members Robo1-4 are
the putative receptors for Slit ligands.
Whereas Robo4 is specifically
expressed in the vascular endothe-
lium (Supp. Fig. S1; Park et al.,
2003), the expression profile of the
three other members during heart de-
velopment has not been analyzed in
detail (Yuan et al., 1999; Camurri
et al., 2004; Jia et al., 2005). In situ
hybridization with Robo1 and Robo2
riboprobes showed that these recep-
tors were both expressed in the ve-
nous pole of the linear heart tube at
E8.5 (Fig. 2A,E). In agreement with a
recent study (Calmont et al., 2009),
we found Robo1 expression in migrat-
ing NCCs (Fig. 2B). At E9.5, Robo1
expression was faintly detected in the
endocardial cushions of the OFT (Fig.
2C). Later, Robo1 expression was
maintained in the great arteries (Fig.
2D). Unlike other Robo genes, a con-
sistent expression of Robo2 was
observed in both atria of the heart at
E10.5 (Fig. 2G). At E12.5, Robo2
expression was observed in the endo-
cardium of the great arteries (Fig.
2H). The specific expression of Slit
ligand and Robo receptor genes in the
venous pole at E8.5 and in the atria
from E9.5 to E12.5 suggests a role for
these molecules in oriented cell
growth and migration during atrial
morphogenesis (Meilhac et al., 2004).
Finally, from our in situ hybridization
analysis we did not detect any expres-
sion of Rig1/Robo3 and Robo4 in the
developing mouse heart at any time-
point analyzed (Supp. Fig. S1).
Dorsoventral Patterning of
Slit3 Is Controlled by Nkx2-5
As noted above, whole-mount in situ
hybridization analysis revealed expres-
sion of Slit3 transcripts in the linear
heart tube at E8.5 (Fig. 1I). At this
stage, Slit3 expression is comparable
to the expression of the basic helix–
loop–helix (bHLH) transcription factor
gene, Hand1, which is restricted to the
ventral wall of the forming heart tube
(Fig. 3A–D; Biben and Harvey, 1997;
Christoffels et al., 2000; Togi et al.,
2004). Although Slit3 is expressed at
high levels in the developing heart,
early cardiac defects have not been
reported in Slit3 mutant embryos (Liu
et al., 2003; Yuan et al., 2003). How-
ever, the expression of Slit3 detected in
the outer curvature of the looped heart
and the enlarged right ventricle
observed in the hearts of Slit3 mutant
mice (Liu et al., 2003), suggest a role
for Slit signaling in ventricular cham-
ber formation. Further studies are
required to determine whether subtle
changes may exist in the heart of these
mutants especially during the forma-
tion of the myocardium chambers and
the great arteries.
We subsequently examined expres-
sion of Slit3 in mutant mice affecting
cardiac morphogenesis. Mutations in
the NK-like homeobox gene, Nkx2-5/
Csx, causes early embryonic lethality
with cardiac development arrested at

















the linear heart tube stage, before
looping (Komuro and Izumo, 1993;
Lyons et al., 1995; Biben and Harvey,
1997). In Nkx2-5!/! embryos, the
early expression of Slit3 was indistin-
guishable from that in control
embryos (Fig. 3E). However, we found
that the dorsoventral pattern of Slit3
expression in the linear heart tube
was perturbed and expression was
observed throughout the mutant
heart tube (Fig. 3E,F). This result
suggests that the myocardium of
Nkx2-5!/! embryos is competent to
express Slit3 but not to interpret sig-
nals that restrict expression on the
ventral side of the heart. Of note, two
putative Nkx2-5 binding motifs
(TGAAGTGATG and TAAAGTGGGT)
are found in a 3,000 bp Slit3 50 proxi-
mal fragment as predicted using
the TFSEARCH program (http://
mbs.cbcr.jp/research/db/TFSEARCH.
html).
Expression of Robo receptor genes
in the venous pole (Fig. 2A,E) incited
us to examine their expression in
Nkx2-5!/! embryos. Of interest, we
did not detect expression of Robo2 in
the linear heart tube of Nkx2-5 mu-
tant embryos (Supp. Fig. S2). This ob-
servation suggests that Nkx2-5 regu-
lates in a different way Slit ligand
and Robo receptor genes during the




Fig. 3. Dorsoventral patterning of Slit3
expression in the linear heart tube requires
Nkx2-5. A: Ventral view of embryo at early
embryonic day (E) 8.5. Slit3 is highly
expressed in the ventral side of the forming
heart tube. B: Section (same embryo as
depicted in A) showing that Slit3 expression in
the heart tube is strictly ventral as delimited
by the arrowheads. C: Expression of Hand1 is
shown as a reference to indicate the ventral
side (arrowheads) of the heart tube at E8.5.
D,E: Comparison of Slit3 expression in wild-
type (WT) and Nkx2-5!/! embryos at E8.5.
D: Lateral view of WT embryo showing high
expression of Slit3 in the ventral side of the
forming heart tube. D0: Section of the embryo
shown in D. Note the expression of Slit3 in
the floor plate (arrow). E: Slit3 expression is
maintained in Nkx2-5!/! embryo. F: Section
(same embryo as shown in E) reveals that
Slit3 is uniformly expressed in heart of Nkx2-
5!/! embryo. ht, heart tube; nt, neural tube.
Fig. 4. Dynamic expression pattern of Slit3
during heart development. In situ hybridization
(A–E) and immunofluorescence (F) were used
to detect spatial expression of Slit3 in hearts
from embryonic day (E) 9 to E10.5.
A,B: Expression of Slit3 is detected in the
whole heart of E9 embryo, whereas it is down-
regulated in the AVC of late E9.5 embryo. C:
Section (same embryo as depicted in B) show-
ing expression of Slit3 in the chambers but not
in the AVC. Note weak expression of Slit3 in the
trabeculae of the left ventricle. D: Lateral view
of E10.5 embryo. High expression of Slit3 is
detected in the left atrium. Note Slit3 expression
in the limb buds and the dermomyotome (white
arrowheads). E: Dissected heart from the
embryo shown in D. High expression is
observed in the right and left atria and the out-
flow tract. F: Expression of Slit3 protein (red) is
detected in the ventricular myocardium and tra-
beculae but not in the AVC of heart at E10.5.
Higher magnification of the trabeculae region
delimited by the dotted line is shown in the
inset. F0: Immunodetection of Slit3 (red) and
DAPI (blue) staining. Note Slit3 expression in
the cytoplasm. ao, aorta; avc, atrioventricular
canal; la, left atrium; lb, limb bud; lv, left ventri-
cle; oft, outflow tract; pt, pulmonary trunk; ra,
right atrium; rv, right ventricle.

















Regulation of the Chamber-
Specific Expression Profile
of Slit3
In looped hearts (E9–E9.5), Slit3
expression was confined to the atrial
and ventricular myocardium but was
clearly absent from the AVC (Fig. 4A–
C), a pattern resembling that of atrial
natriuretic factor (ANF; see Supp.
Fig. S3A), Chisel, and Connexin40 at
this stage (Christoffels et al., 2000).
At E10.5 and E12.5 Slit3 expression
was restricted to the atria and the
OFT (Figs. 1L, 4C–E). Immunohisto-
chemistry revealed Slit3 protein
expression in both atrial and ventric-
ular myocardium at E10.5 (Fig. 4F).
The AVC region was negative, con-
firming our results by in situ hybrid-
ization. Detection of Slit3 protein but
not mRNA in the ventricles of the
heart at E10.5 (Fig. 4E,F) indicates a
persistence of the protein in the
chamber myocardium. Although Slit3
expression overlaps with Robo1 and
Robo2 in the venous pole and later
only with Robo2 in the atria, no Robo
receptor genes were detected in the
ventricular myocardium of the heart
(Fig. 2). Despite its favorite link with
Robo receptors, Slit contains domains
that suggest association with the
extracellular-matrix receptors (Che-
dotal, 2007). Furthermore, recent
study in Drosophila have proposed
that Slit is localized on cardiac cells
by association with Dystroglycan
(Dg), a proteoglycan (Medioni et al.,
2008), and possibly also with aPS3/
bPS1 Integrin (MacMullin and
Jacobs, 2006).
The absence of Slit3 gene expres-
sion and protein in AVC myocardium
suggested potential regulation by the
T-box transcriptional repressors Tbx2
and Tbx3 that are restricted to non-
chamber myocardium (Supp. Fig.
S3B,C), where they repress the cham-
ber transcriptional program (Habets
et al., 2002; Christoffels et al., 2004b;
Harrelson et al., 2004; Bakker et al.,
2008; Mesbah et al., 2008). Therefore,
we examined Slit3 expression in mu-
tant embryos deficient for Tbx2 and
Tbx3. In situ hybridization on stage-
matched embryos revealed activation
of Slit3 in the AVC of E10.5 Tbx2!/!
but not Tbx3!/! hearts (Supp. Fig.
S4). This observation indicates that
Tbx2 alone is sufficient to repress
Slit3 in the nonchamber myocardium
of Tbx3!/! hearts, consistent with
previous findings on other chamber-
specific genes (Bakker et al., 2008;
Mesbah et al., 2008). The T-box factor
Tbx20 is essential for embryonic
chamber formation through its nega-
tive regulation of Tbx2 in the myocar-
dium and endocardium (Cai et al.,
2005; Singh et al., 2005; Stennard
et al., 2005; Takeuchi et al., 2005). To
test the hypothesis that ectopic Tbx2
expression may be able to repress
Slit3 in the forming heart, we ana-
lyzed Slit3 expression in Tbx20!/!
embryos. Mutant embryos showed
severe cardiac abnormalities includ-
ing rudimentary ventricular cham-
bers that did not further differentiate
(Stennard et al., 2005). We could not
detect any Slit3 expression in
Tbx20!/! hearts at E9 (compare Fig.
5B,B0 with 5A,A0). Of interest, Dro-
sophila Slit is also perturbed in the
embryonic heart tube of Tbx20-ortho-
log (H15nmr) mutants (Qian et al.,
2005), suggesting a high evolutionary
conservation of this regulation path-
way. We also examined Slit3 expres-
sion in embryos misexpressing Tbx2
throughout the embryonic heart
under the control of the XMLC2 pro-
moter (XMLC2-rtTA/tetO-Tbx2;
(Dupays et al., 2009). Consistent with
our observation in Tbx20!/! embryos,
Slit3 expression was significantly
reduced (Fig. 5C,C0). The residual
weak expression of Slit3 observed in
these embryos may be explained by
the mosaic expression of the trans-
gene at this stage (Dupays et al.,
2009). Moreover, we found three con-
served T-box binding elements (TBEs;
Kispert and Herrmann, 1993; Sinha
et al., 2000) in the Slit3 50 proximal
promoters (Fig. 5D). The requirement
of these TBEs for repression in the
AVC and the complementary expres-
sion pattern between Tbx2 (Supp.
Fig. S3) and Slit3 (Fig. 4B) prompted
us to study the interaction of Tbx2
with the TBE motifs identified in the
Slit3 promoter using electrophoretic
mobility shift assay (EMSA) experi-
ments. Oligonucleotide probes corre-
sponding to the three TBE motifs
were used. Tbx2 bound to the wild-
type TBE2 motif but not TBE1 and
TBE3, because a shifted band was
detected only in lanes 11 and 12 (Fig.
5E). However, when the EMSA was
performed with a mutated TBE2
motif this binding was abolished (Fig.
5E). Together these results suggest
that Slit3 expression may be directly
repressed by Tbx2 during AVC
formation.
Conclusion
In this study, we have characterized
Slit ligand and Robo receptor gene
expression in the developing mouse
heart. Our results suggest that Slit-
Robo signaling, essential for morpho-
genesis of the Drosophila heart tube,
may play roles in oriented cell growth
during atrial and ventricular morpho-
genesis in vertebrates. Furthermore,
we identify two upstream regulators
of Slit3 expression, the predominant
Slit ligand expressed in the early
mouse heart: analysis of Slit3 expres-
sion in different mutant mouse
embryos reveals that Slit3 is re-
stricted to the ventral wall of the lin-
ear heart tube by Nkx2-5 regulated
mechanisms and excluded from AVC






All experiments involving animals
were performed in accordance with
French guidelines on the care and use
of laboratory animals. After death by
CO2 asphyxiation, embryo mice were
removed from timed-pregnant CD1 or
mutant mice. The day of vaginal plug-
ging was defined as 0.5. Embryos
were genotyped by polymerase chain
reaction (PCR) using genomic DNA
isolated from yolk sacs. The null al-
leles Tbx2tm1Pa, Tbx3tm1Pa, Tbx20lacZ,
and Nkx2-5gfp (hereafter referred
to as Tbx2!, Tbx3!, Tbx20!, and
Nkx2-5!) were maintained on a mixed
genetic background (Biben et al.,
2000; Davenport et al., 2003; Harrel-
son et al., 2004; Stennard et al.,
2005). Somites were counted for de-
velopmental staging and a sample of
the yolk sac was taken for PCR geno-
typing using the following primers.
Tbx3: the primers 50-GGC CTC AAG
TAG CTT GGA A-30, 50-AGG CCA

















ACA GAA GAG CAG A-30, and 50-CTA
AGC CTG ATG GTG TGA G-30 result
in a 350 bp wild-type band and a 500
bp mutant band. Tbx2: the primers 50-
CCA GCC AGG GAA CAT AAT GAG
G-30, 50-CTG TCC CCT GGC ATT
TCT GG-30, and 50-CCT GCA GGA
ATT CCT CGA CC-30 result in a 180
bp wild-type band and a 88 bp mutant
band. Nkx2-5: the primers 50-GAA
CCT GGA GCA GCA GCA GCG TAG
C-30 and 50-CAG AAG GGA AGA GCT
TGA GGT TCT C-30 result in a 308 bp
wild-type band and a 1,376 bp mutant
band.
The tetO-Tbx2 and xMlc2-rtTA
transgenes have been previously
described (Dupays et al., 2009). Doxy-
cycline was administered to pregnant
females either by intraperitoneal
injection (2 mg of Dox in 0.5 ml of
0.9% aqueous NaCl) at the indicated
stage or by means of food (2 mg of Dox
in 0.5 ml of 0.9% aqueous NaCl) from
stages specified.
For early developmental stages
whole embryos were fixed in 4% para-
formaldehyde (PFA) in phosphate buf-
fered saline (PBS) overnight at 4!C,
dehydrated and kept in methanol.
Hearts or trunks were dissected and
fixed in 4% PFA in PBS overnight at
4!C, transferred to 15% sucrose in
PBS, followed by 15% sucrose 7% gel-
atin, and frozen in liquid nitrogen
before cryo-sectioning at 10 mm.
Whole-Mount In Situ
Hybridization
Whole-mount in situ hybridization
was carried out as published (Zaffran
et al., 2004). Probes were labeled
according to the manufacturer’s
instruction using the digoxigenin
(DIG) -RNA labeling mix (Roche). The
probes used for in situ hybridization
were mSlit2 and mSlit3 (Yuan et al.,
1999), rat Slit1, Robo1, Robo2 (Kidd
et al., 1998), Rig1/Robo3, and
mRobo4 30-untranslated region
Fig. 5. Disrupted cardiac expression of Slit3 in Tbx20 mutant and in Tbx2-misexpression embryos. A–C: Lateral views of wild-type (WT),
Tbx20"/" mutant and Tbx2-misexpressing embryos. A0–C0: Sections of embryos shown in A–C. While Slit3 is present in the forming heart of WT
embryo (A,A0), its expression is not detected in the heart of E9 Tbx20"/" embryo (B,B0). C,C0: Slit3 expression is highly reduced in heart misex-
pressing Tbx2. D: Sequence of three-conserved T-box binding elements (TBE) found in a Slit3 50 proximal promoter. Numbers indicate position of
the sequences from the ATG. TBE sequence shows the T-box binding site as determined previously (Kispert and Herrmann, 1993). E: Electropho-
retic mobility shift assay shows that Tbx2 binds to the wild-type TBE2 motif (lanes 9–12) but not to the TBE1 (lanes 1–8) and TBE3 (lanes 17–23)
motifs. Mutation of the TBE2 motif impairs Tbx2 binding (lanes 13–16). la, left atria; lv, left ventricle.

















(obtained by PCR). Hybridization sig-
nals were then detected by alkaline
phosphatase (AP) -conjugated anti-
DIG antibodies (1/2,000; Roche),
which were followed by color develop-
ment with NBT/BCIP (nitroblue tet-
razolium/5-bromo-4-chloro-3-indolyl
phosphate) substrate (Promega). Af-
ter staining, the samples were washed
in PBS and post-fixed. Embryos were
imaged using a Zeiss Lumar stereomi-
croscope coupled to an Axiocam digi-
tal camera (AxioVision 4.4, Zeiss).
The number of embryos examined
was at least 3 for each stage.
Immunohistochemistry
For immunohistochemistry, sections
were incubated as described previ-
ously (Zaffran et al., 2004). The Slit3
antibody, C-20, was a polyclonal anti-
body raised against a peptide map-
ping within an internal region of Slit3
of human origin from Santa Cruz,
used at 1/50 dilution. The Robo1 and
Robo2 antibodies were polyclonal
antibody raised against ectodomains
of rat Robo1 (amino acids 1-892) and
rat Robo2 (amino acids 1-855) as
described previously (Tamada et al.,
2008). Secondary antibodies were
donkey anti-goat or anti-rabbit, Alexa
488 used at 1/500 dilution (Molecular
Probes). Sections were photographed
using a Zeiss Axiovert 200M micro-
scope with an Axiocam camera (Axio-
Vision 4.4, Zeiss).
DNA-Binding Assay
For EMSA, the Tbx2 protein was pro-
duced with the TNT (T7) -coupled in
vitro transcription/translation system
(Promega). Production yields of Tbx2
protein was estimated by [35S]methio-
nine labeling. EMSAs were performed
in a 20-ml volume on ice with 104 cpm
(0.5 ng) of either probes. Probes used








CACTAAT) from the Slit3 promoter.
Briefly, 3 or 9 ml of Tbx2 protein was
gently added and incubated for 30 min
with labeled probes and 0.1 mg of non-
specific competitor poly[(dC)] in a bind-
ing buffer 5! composition of 20% glyc-
erol, 50 mM Tris-HCl pH7.5, 250 mM
NaCl, 2.5 mM ethylenediaminetetra-
acetic acid, 2.5 mM dithiothreitol, and
0.25 mg BSA then loaded on a 4% poly-
acrylamide gel in 0.25! TBE buffer.
The gel was dried and analyzed with a
PhosphoImager.
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Diverse functional networks of
Tbx3 in development and disease
Andrew J. Washkowitz, Svetlana Gavrilov, Salma Begum
and Virginia E. Papaioannou∗
The T-box transcription factor Tbx3 plays multiple roles in normal development
and disease. In order to function in different tissues and on different target
genes, Tbx3 binds transcription factors or other cofactors specific to temporal or
spatial locations. Examining the development of the mammary gland, limbs, and
heart as well as the biology of stem cells and cancer provides insights into the
diverse and common functions that Tbx3 can perform. By either repressing or
activating transcription of target genes in a context-dependent manner, Tbx3 is
able to modulate differentiation of immature progenitor cells, control the rate
of cell proliferation, and mediate cellular signaling pathways. Because the direct
regulators of these cellular processes are highly context-dependent, it is essential
that Tbx3 has the flexibility to regulate transcription of a large group of targets, but
only becomea active on a small cohort of themat any given timeor place.Moreover,
Tbx3must be responsive to the variety of different upstream factors that are present
in different tissues. Only by understanding the network of genes, proteins, and
molecules with which Tbx3 interacts can we hope to understand the role that Tbx3
plays in normal development and how its aberrant expression can lead to disease.
Because of its myriad functions in disparate developmental and disease contexts,
Tbx3 is an ideal candidate for a systems-based approach to genetic function and
interaction.  2012 Wiley Periodicals, Inc.
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INTRODUCTION
The T-box family of genes is an ancient andevolutionarily conserved group of transcription
factor genes defined by their DNA-binding domain,
known as the T-box. First discovered in mouse, the
T-box family derives its name from the mesoderm-
specification gene Brachyury (T).1 Each T-box factor
binds a specific core sequence, the T-half-site, found
in the promoters of target genes, often in tandem
or in different orientations. These T-half sites are
accompanied by other transcription factor binding
sites, giving them specificity.2 It is the interactions
with these other transcription factors that allow
T-box genes to play a variety of roles during disparate
development processes.3
∗Correspondence to: vep1@columbia.edu
Department of Genetics and Development, Columbia University
Medical Center, New York, NY, USA
The 17 members of the T-box gene family in
mouse have been grouped into five subfamilies based
on sequence similarity. Tbx3 is a member of the Tbx2
subfamily, a group that also includes Tbx2, Tbx4, and
Tbx5. This subfamily arose during a tandem duplica-
tion event followed by chromosomal duplication and
dispersion. Tbx3 and Tbx2 are closely related mem-
bers sharing 90% amino acid identity in the T-box
and having many overlapping areas of expression.4
During normal mouse development, Tbx3
expression begins in the inner cell mass of the
blastocyst, and then appears in the extraembryonic
mesoderm during gastrulation. During organogenesis,
Tbx3 is expressed in the nervous system, skeleton, eye,
heart, kidney, lungs, pancreas, and mammary gland.5
There are two known isoforms of Tbx3 that result
from differential splicing in the second intron, Tbx3
and Tbx3+2a, which includes 20 extra amino acids in
the DNA binding domain of the protein.6 While both
have been detected, there is no known unique role for






one or the other specific isoform in development.
A null allele of Tbx3 has been generated and
homozygous mutant mice have defects in a number
of structures such as the limbs, mammary glands, and
heart. These mutants die by embryonic day (E) 16.5
with greater than 50% dead by E11.5, most likely
because of yolk sac defects. A number of different
organ-specific effector genes and transcription factors
are aberrantly expressed in these mutants.7
In humans, TBX3 mutations have been linked
to ulnar-mammary syndrome (UMS, MIM 181450),
a disease with variable penetrance characterized by
shortened forelimbs, defective apocrine gland and
genital development, and heart abnormalities.8,9 This
phenotype is similar to that seen in Tbx3mutant mice,
although in humans the phenotype is seen in heterozy-
gotes whereas in mice, only homozygotes have severe
defects. The spectrum of affected organs in UMS is
characteristic of diseases associated with T-box fac-
tors and is indicative of the complex transcriptional
networks in which these genes participate during
development.10 Tbx3 mutations have also recently
been found to impact the pluripotency of embryonic
stem cells and the invasiveness of cancer.11–15
For Tbx3 to play a part in the development of so
many different organs, it must interact with a network
of genes and proteins specific to each spatial and tem-
poral location of action. While Tbx3 most likely binds
to its target promoters as a monomer, other factors
are known to enhance Tbx3-mediated transcriptional
activation or repression, hinting at a large network
of factors that give specificity to Tbx3 activity.16,17 In
addition, Tbx3 has been shown to have both activa-
tion and repression domains which may be modulated
by other cofactors to ensure the proper function of the
protein in each context.18 Only by understanding the
function of Tbx3 by a systems approach in a variety
of developmental contexts can we hope to unravel the
network of genes of which Tbx3 is a part.
Tbx3 IN DEVELOPMENT
Tbx3 in Mammary Gland Development
The initiation and growth of the mammary gland
is dependent on fibroblast growth factor (FGF)
and WNT signaling and involves reciprocal inter-
actions between the epidermis and the underlying
mesenchyme in bilateral ‘milk lines’. Mesenchyme
induces the formation of mammary placodes in five
specialized areas along each flank of the embryo.
The epidermal placode forms a mammary bud which
in turn influences the surrounding mesenchyme to
form the primary mammary mesenchyme. Tbx3 is
initially expressed in the mesenchyme of the milk line
prior to placode formation and then appears in the
mammary placodes as one of the earliest markers of
mammary epithelium. Expression in the mesenchyme
gradually decreases while epithelial expression is
maintained.5,7,19,20 During late gestation, Tbx3 is
expressed in mammary mesenchyme surrounding the
nipple (Figure 1(a)) and in postnatal females it has
been detected in virgin, pregnant, lactating and invo-
luting mammary glands.21
UMS in humans is characterized by variable
abnormalities of the mammary gland ranging from
normal to hypoplastic breasts, with missing or super-
numerary nipples. A loss of function mutation of
mouse Tbx3 results in the failure of mammary pla-
code induction in homozygous females and aplasia or
a decrease in the extent of branching of the ductal tree
in heterozygous females. This effect on the developing
mammary gland is independent of the repression of
the Tbx3 target gene p19ARF.19 Although there is no
evidence regarding the direct regulation of Tbx3 in
mammary gland development or on its direct down-
stream targets, bothWNT and FGF signaling feed into
the Tbx3 regulatory network. Fgfr2b and Fgfr1/2c are
upstream of Tbx3 expression, and Wnt10b, Lef1,
and FGF signaling are all lost in the absence of
Tbx3,7,20 indicating feed-forward and feedback loops
of regulation for the maintenance and/or induction of
Tbx3 expression (Figure 2). Similarly, Bmp4 overex-
pression inhibits Tbx3 expression in the mammary
mesenchyme while, reciprocally, overexpression of
Tbx3 represses Bmp4.22 Tbx3, in combination with
FGF signaling, may be upstream of Nrg3, a growth
factor implicated in the initiation of mammary pla-
codes, but the evidence is circumstantial.23,24
The closely related T-box gene, Tbx2, is
expressed in the mesenchyme but not the epithelium
duringmammary development and althoughmutation
of Tbx2 by itself does not result in a mammary gland
phenotype, a genetic interaction with Tbx3 is evident
in double heterozygous females by an exacerbation of
mammary aplasia.19
Tbx3 in Limb Development
In vertebrates, limbs develop as a set of lateral bulges
from the lateral plate mesoderm on either side of
body axis. The initial events in limb development
involve proliferation of the lateral plate mesoderm
and induction of the apical ectodermal ridge (AER).25
Three signaling centers, the AER, the zone of polar-
izing activity (ZPA) and the nonridge ectoderm, are
necessary for growth and patterning of limb buds, pro-
cesses which involve complex signaling through the
FGF and Sonic hedgehog (SHH) pathways.26 All four
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FIGURE 1 | Expression of Tbx3 (blue) in developing organ systems at different stages. (a) In mammary gland, Tbx3 is first expressed at E10.5 in
the mesenchymal milk line and then appears as one of the earliest markers of the epithelial thickenings known as the mammary placodes. It
continues to be expressed in the epithelium as the placode expands into the mammary bud and eventually forms the branching ductal system. Near
term (E18.5), mesenchyme surrounding the nipple expresses Tbx3. (b) Tbx3 is first expressed in the posterior margin of the early limb buds and then
in the posterior and anterior margins of both fore and hind limbs by E10.5. It is also expressed in the AER, continuously at first and then limited to the
tips of the digits by E12.5. (c) Tbx3 is expressed in the AVC, SAN, OFT and atrioventricular bundle (AVB) starting around E10.5. It fully delineates the
cardiac conduction system at E14.5 with expression in the SAN, AVN, AVB, and the bundle branches (BB).
members of the Tbx2 subfamily are expressed during
limb development. In mice, Tbx3 expression is first
detected at the posterior margin of the early limb buds,
and shortly thereafter in the anterior and posterior
proximal mesenchyme and AER. As the limb bud
elongates, Tbx3 anterior and posterior expression
domains are expanded in the mesenchyme. By E13.5,
expression in the AER is limited to the tips of the
digits5,27(Figure 1(b)). A similar pattern is observed in
the chick.28–31
In UMS, posterior structures of the fore limb,
for example, the ulna and the fifth digit are missing.8
Mice homozygous for the Tbx3 null allele simi-
larly exhibit missing or abnormal posterior fore limb











































FIGURE 2 | Diagram of known regulatory pathways and downstream targets of Tbx3 in the development of heart, mammary gland and limbs, as
well as in embryonic and iPS stem cells. The variety of factors involved illustrates the context-dependent nature of Tbx3 interactions.
elements, but unlike UMS also show severe hind limb
abnormalities.7
Little is known about the direct regulation of
Tbx3 in limb development. Studies in the chick
indicate that Tbx3 expression in the posterior of
the limb buds is controlled via different mechanisms
than in the anterior. The posterior domain of Tbx3
expression depends on the ZPA signaling cascade
and is regulated positively by Shh, but the anterior
expression domain is negatively regulated by Shh and
is dependent on continuous signaling by anteriorly
produced BMPs, suggesting a potential role for Tbx3
in the antero-posterior patterning of the limb.31
A recent study places retinoic acid (RA) signaling
upstream of Tbx3 in the limbs (RD Ballim, C
Mendelsohn, VE Papaioannou, S Prince, personal
communication). In mice, Shh and Hand2 appear
to be downstream targets of Tbx3.7 Studies in chick
have implicatedTbx3 in positioning the limb along the
main body axis through a genetic interplay between
Hand2 and Gli3, but the interrelationship of these
genes is not clear.32 Inactivation of Dicer in mice
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results in a posterior shift and a delayed formation
of hind limb bud which is accompanied by altered
transcription of Tbx3, Hand2 and Gli3. This study
showed that microRNA is also capable of inhibiting
Tbx3 and Hand2 expression in vitro. Hence, Tbx3
and Hand2 might be downstream of Dicer-mediated
regulation in limb bud positioning33 (Figure 2).
Tbx2 has a similar spatiotemporal expression
pattern in limb buds in both chick and mice27,29–31
and is downregulated in Tbx3 mutants.7 Experiments
in the chick have shown that Tbx3 and Tbx2 together
specify the identity of posterior digits, acting through
regulation of interdigital BMP signaling,34 possibly
indicating a genetic interaction.
Tbx3 in Heart Development
The transformation from linear heart tube to the four-
chambered heart is accomplished by the differential
cell growth and distinct gene programs adopted
by different regions in the heart. Starting at E9.5,
the working myocardium cells undergo rapid and
sustained proliferation to form the muscular chambers
of the heart. The intervening regions of non-
chamber myocardium, meanwhile, are held relatively
mitotically inactive to form the constrictions between
the chambers that will eventually become components
of the cardiac conduction system (CCS).
Tbx3 expression is first detected in the heart
at E8.5 and as the heart undergoes looping Tbx3
expression delineates the developing nodal conduc-
tion system with expression in the sinoatrial node
(SAN) and atrioventricular node (AVN), as well as
the endocardial cushions in the atrioventricular canal
(AVC) and themesenchyme of the outflow tract (OFT)
(Figure 1(c)). This expression pattern is almost iden-
tical to that of Tbx2 although no genetic interaction
has been demonstrated in this tissue. Tbx3 is thought
to have two distinct roles in the developing CCS: first,
the modulation of cell division resulting in constric-
tions between chambers, and secondly, the repression
of a chamber-specific gene program and concomi-
tant promotion of a conduction system-specific gene
program. Despite the assumption that Tbx3 mutant
embryos die at midgestation due to yolk sac deficien-
cies, their hearts have altered morphology including
double outlet right ventricle, incomplete ventricular
septation, and delayed aortic arch formation.35 These
malformations are a result of increased cell division in
the AVC and OFT leading to a lack of constriction.36
Mutant hearts also have ectopic expression of cham-
ber myocardium genes, such as Cx40, Cx43, and
Nppa, in the non-chamber AVC, a phenotype resem-
bling that of Tbx2 mutants. Conversely, CCS-specific
genesHcn4 and Lbh are upregulated in regions where
Tbx3 ectopic expression is induced, and functional
conduction tissue develops37 (Figure 2).
On a protein level, it appears that Tbx3
regulates its targets by cooperatively binding their
promoters along with other transcription factors. For
example, Tbx3 has been shown to bind cooperatively
with Msx1 and Msx2 in the repression of Cx43.16
Similarly, Tbx2 has been shown to bind to Nkx2.5
and repress Nppa, a known Tbx3 target. However,
in the absence of Tbx2, Tbx5 binds to Nkx2.5
and activates Nppa38 (Figure 2). This suggests a
regulatory mechanism whereby binding competition
with a network of transcription factors determines
which gene programwill be expressed in a given tissue.
Tbx3 mutant heart abnormalities result from
increased cell division in the regions of Tbx3 expres-
sion implicating Tbx3 in the regulation of cell dynam-
ics in the process of heart looping and growth.
Conversely, despite its role in the regulation of the
gene expression profile of the CCS, Tbx3 mutant
hearts have normal conduction velocity and several
of the conductive structures are present. This dis-
crepancy is likely due to the functional overlap of
Tbx3 with Tbx2, which has been shown to bind to
and regulate many of the same targets. Nonetheless,
some patients with UMS show conduction defects
in line with abnormal development of conduction
structures.9 These defects are similar to those in mice
mutant for Tbx2, highlighting the potential functional
overlap with Tbx3 in the development of the CCS.39
Tbx3 IN STEM CELL BIOLOGY
In addition to its key roles in development, Tbx3 also
plays a role in both the establishment and mainte-
nance of pluripotency in embryonic stem (ES) cells
and induced pluripotent stem (iPS) cells. ES cells are
derived from the inner cell mass (ICM) of preimplanta-
tion blastocysts and rely on the LIF/STAT3 pathway
to maintain pluripotency. In the embryo, Tbx3 is
first expressed in the ICM7 and this expression is
recapitulated in ES cells. Tbx3 expression is highest
when ES cells are undifferentiated and decreases as
cells differentiate into embryoid bodies, suggesting its
importance in the maintenance of pluripotency.13
In ES cells, Oct4 and Nanog, two recognized
markers of pluripotency, act as repressors of differen-
tiation toward a trophectoderm and endodermal fate,
respectively. Similarly, Tbx3 is able to block differen-
tiation into mesoderm, ectoderm, trophectoderm, and
neural crest cell fates.11,13 ES cells treated with shRNA
against Tbx3 downregulate both Oct4 and Nanog,
and show differentiated morphology and reduced






alkaline phosphatase activity. To function as a medi-
ator of pluripotency, Tbx3 is able to act with Klf4 to
regulate the expression of Nanog specifically, lying at
the center of a LIF-independent pluripotency pathway
in ES cells.40 In addition to blocking differentiation,
Tbx3 also appears to play a role in the differentiation
of ES cells into extraembryonic endoderm (ExEn) as
overexpression of Tbx3 in ES cells induces differen-
tiation into cells with ExEn morphology as well as
expression of ExEn markers such as Gata6.13 This
dual functionality suggests that Tbx3 takes part in a
complex regulatory network where it is able to func-
tion both as a repressor of specific cell fates and an
activator of others. In this way, ES cells are poised to
differentiate into a given cell type quickly when the
proper signals are received: the relief of one repression
module allows the activation of another. The com-
plexity of Tbx3 in the pluripotency network is evident
as the promoter of Tbx3 itself is bound by a number of
transcription factors at the core of the genetic regula-
tion circuit of pluripotency12 (Figure 2). Mechanisti-
cally, Tbx3 is able to regulate transcription at the level
of DNA, but also on an epigenetic level: Tbx3 binding
to the Gata6 promoter is necessary to activate tran-
scription but Tbx3 is also able to mediate the histone
methylation of H3K27me3 at the Gata6 promoter.13
In addition to the maintenance of pluripotency,
Tbx3 may also play a role in the establishment
of pluripotency in iPS cells. Fibroblasts with
induced expression of Tbx3 in combination with
the reprogramming factors Sox2, Oct4, and Klf4
express pluripotency markers more rapidly than
fibroblasts without. Moreover, iPS cells with induced
Tbx3 expression contributed to enhanced germ line
contribution and transmission.41
Tbx3 IN CANCER
Tbx3 is amplified and/or overexpressed in many
tumors42–55 (Table 1). Accumulating evidence sug-
gests that Tbx3 contributes to tumorigenesis through
interaction with components of several major onco-
genic pathways (Figure 3), some with which Tbx3
is known to interact in other contexts. Activation
of the canonical Wnt-β-catenin pathway has been
linked to many types of cancer. β-Catenin plays
dual roles depending on intracellular localization: in
the nucleus it acts as the main effector of WNT
signaling and at the plasma membrane as a compo-
nent of adherens junctions where it links E-cadherin
with the actin cytoskeleton.56 Tbx3 is a downstream
target of the Wnt-β-catenin pathway in liver tumori-
genesis, and recent evidence suggests that there is
a feedback loop by which Tbx3 can upregulate β-
catenin.46 Thus, Tbx3 could be a critical mediator of
cellular responses to proliferative and anti-apoptotic
signals delivered by β-catenin. Interestingly, Tbx3
represses E-cadherin,47 which has been implicated
in metastasis of invasive epithelial tumors.57 Together
these findings suggest that Tbx3 can enhance tumor
invasiveness through both E-cadherin repression and
β-catenin upregulation. Additionally, phorbol ester
12-O-tetradecanoylphorbol-13-acetate (TPA) treat-
ment leads to downregulation of E-cadherin, and as
TPA activates TBX3 in a PKC-dependent manner,58
it is possible that upregulation of TBX3 is mediating
this process.
As in normal mammary gland development, FGF
signaling is upstream of TBX3 expression in breast
cancer.61 Moreover, estrogen can upregulate TBX3
levels in breast cancer via paracrine FGF9–FGFR3 sig-
naling and the upregulation of TBX3 expands the pool
of functional estrogen receptor (ER) -negative cancer
stem-like cells. This implies that resistance to anti-
estrogen therapy which is common in breast cancer
might be accompanied by an increase in FGF–TBX3
signaling and a consequent increase in the propor-
tion of cancer stem-like cells. Thus, targeting of the
FGF–TBX3 pathway could be a useful strategy for
refractory breast cancers. Moreover, TBX3 can affect
the equilibrium of cell type differentiation within
breast epithelial cancers, which is context-dependent
for a given cancer cell population.62 Together these
studies suggest that TBX3 could play important roles
in cell plasticity within breast cancer.
Upregulation of Tbx3 suppresses the expression
of ARF (p19ARF in mouse and p14ARF in humans)
and possibly p16INK4a and promotes the bypass of
senescence through inactivation of p53 via ARF-
MDM2-p53 tumor suppressor pathway.15,23,42,63,64
Tbx3 can also directly repress the p21Cip1/WAF1
promoter6 and bypass senescence independently of
p53. The knockdown of Tbx3 in both melanoma
and breast cancer cell lines leads to reduction in
anchorage-independent growth, migration and tumor
formation, and a decrease in pro-senescence factors
that results in increased proliferation.14 It was pre-
viously suggested that Tbx3 and its splice variant
Tbx3+2a, are functionally distinct in inhibition of
senescence.42 However, a subsequent study convinc-
ingly demonstrated that both isoforms function as
anti-senescence factors, bind the same T-half-site and
target the same genes.6 Also, Tbx3 can promote
Ras and c-Myc associated transformation.15,65 These
findings together imply that Tbx3 cooperates with
oncogenic Ras and c-Myc by suppressing ARF activ-
ity. A recent study identified GATA3 and GLI3 as
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TBX3 Expression Method of Detection Corresponding Normal Expression of Tbx3 References
Breast 48/50 (96) WB and real time PCR Mammary epithelium and mesenchyme of
developing gland
42,44,51
Melanoma1 7/12 (58) WB Melanocytes2 47
Pancreatic 7 Microarray Developing pancreas 53,55,59
Cervical 48 Microarray Unknown 45
Ovarian 21/29 (70) MALDI-Tof-MS Not detected (unpublished) 44
Prostate ND GWAS Adult prostate 42,43,49
Colorectal 1 RT-PCR Adult colon 42,52
Liver (70–87) Microarray and WB Hepatoblasts 46,60
Gastric 1 Microarray Developing stomach 50,59
Glioblastoma ND Microarray Developing CNS 54
Pheochromocytoma ND Microarray Adult adrenal gland 42,48
GWAS, genome-wide association study; ND, not determined; MALDI-Tof-MS, matrix-assisted laser desorption/ionization time of flight mass spectrometry;
RT-PCR, reverse transcriptase–polymerase chain reaction; WB, western blot.
Cancers listed are those in which TBX3 has been shown to be amplified and/or overexpressed.
1Melanoma cell lines in vitro.



























FIGURE 3 | The Tbx3 interactome in cancer. Known and hypothetical molecular interactions between Tbx3 and components of several signaling
pathways important in oncogenesis are drawn from a variety of contexts.
putative TBX3 downstream targets in breast cancer.66
Although chromatin immunoprecipitation analysis
confirmed direct binding of TBX3 to both of these tar-
gets, the functional significance of these findings is not
known. Interestingly, GATA3 was shown to inhibit
breast cancer metastasis by directly upregulating
E-cadherin levels.67 It is tempting to speculate that
TBX3 could be repressing GATA3 or alternatively
affecting E-cadherin levels by binding to both GATA3
and E-cadherin. Gli3 belongs to the hedgehog
(Hh) signaling network and is required for normal
mammary bud formation.68 As deregulation of Hh






pathway is implicated in a wide variety of aggres-
sive and metastatic cancer, the predicted Tbx3–Gli3
interaction warrants further investigation.
CONCLUSION
The Tbx3 transcriptional network is highly con-
text dependent. This flexibility allows the protein to
assume different functions that are specialized for the
time and place of expression. Nonetheless, there are
common themes that run through the network that
hint at more general functions for the gene. In the
heart and ES cells, Tbx3 blocks the differentiation of
multipotent tissues. This inhibition of differentiation
may play a role in cancers when Tbx3 is overex-
pressed or amplified: induction of an undifferentiated
‘stem-like’ cancer cell by Tbx3 may initiate the pro-
cess of tumor formation and cell migration. This
repressive function is evident in in vitro assays where
a transcriptional repression module has been noted.69
Conversely, Tbx3 can induce differentiation in differ-
ent contexts. In ES cells, for example, Tbx3 promotes
differentiation into ExEn. In the mammary gland as
well, Tbx3 induces differentiation of the mammary
placodes. Indeed, by binding to tissue-specific tran-
scription factors, Tbx3may be able to either repress or
activate the differentiation of multipotent progenitors
in a context-dependent manner.
Tbx3 also appears to play a role in cell prolifer-
ation in a number of different contexts: in the heart,
Tbx3 depletion leads to an excess of cell proliferation
in the structures where it is normally expressed. Cell
proliferation might also be altered in the limb in
the absence of Tbx3 as mice deficient for the gene
have shortened fore and hind limbs, a phenotype
that is largely recapitulated in human UMS. This
role is highlighted in cancers where TBX3 is over-
expressed or amplified as it results in the bypass of
senescence through inactivation of the p53 pathway,
while the knockdown of TBX3 leads to an increase in
proliferation.
Finally, Tbx3 appears to play a role as a medi-
ator of cellular signaling by modulating a number of
signaling pathways. Tbx3 can control WNT signal-
ing in the mammary gland and limb buds, as well
as in various cancer models. FGF and SHH signaling
are also modulated by Tbx3 in various contexts. As
with cell proliferation, Tbx3 may be able to regulate
these pathways generally, but rely on specific signals
to impart specificity to this function.
In order for it to assume such distinct functions,
Tbx3 interacts with other factors to give a regional
and temporal specificity to its action. Given the evi-
dence of Tbx3 functioning in protein complexes with
transcription factors of myriad different families and
as a competitor for binding to transcriptional tar-
gets, it is reasonable to conclude that Tbx3 is able to
mediate a specific set of activities, but that available
cofactors determine how it will act in specific contexts.
The necessity of these cofactors in determining what
function Tbx3 will have makes it an important target
for studying with a systems-based approach.
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